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I}jTRODUCTIO:N
Blood is an important pa.rt af the the�apy of many
conditions.

it is the purpose of this paper to discuss

the more important ones.

lio attempt will be made to

report all of the diseases in which blood has been tried;
a list of them would correspond almost exactly with the
table of contents or any good t�xthook of medicine. to

which the reader is referred if he desires such a lis�.
Blood has been used on numberless occasions in hope�
less cases. or in diseases of unknown etiology.

lt may

be stated that without exception, any disease for which
no effective treatment is known has been treated with
blood by someone.

Occasional successes have been scored,

especially in conditions with a tendency to spontaneous
remission.

These have been reported, while the failures,

in general, have not.

Hence the literature is full of

isolated reports which. are difficult to assemble, and are
of litt.l,e value when they are.

Some of the more important

of these will be mentioned brie.fl.y; the maj ori·ty will not
appear in this paper.
The status of the use of blood depends up�n the exact
development of medical science.
tially replacement therapy.

BJ.cod therapy is essen

Something must be miss�ng from

the body of the patient which can be supplied by the blood

l

of the donor.

lb'ery time research identifies one of

these suhatanees and finds a way to supply it separat&ly,
one more indication for transfusion is considered obso
lescent ..
The trend at the present time is to isolate the

speetfi� substances of blood so that they may be used
separately.

The first such derivatives to make theu

appearance were plasma and serum.

Later came red cell

suspensions; more recently the piasma fractionation pro
gram has separated the plasma proteins into albumins and
globulins, each with individual uses and indications.
These derivatives are of suah importance. that in
many conditions they have taken the place of who�e blood.

A diacui:,sion o:f the use of blood whiah omitted their men

tion would be of little value.
This paper will contain a review of the indicatiops
for transfusion of blood and its derivatives which are of
importanc,e at the present time, or which have been of

In eac.h caaa the rationale, if

importance in the past.

any. will be discussed, and the developme nt will be summa

rized.

An attempt will be made to answer the following

questions:

WHEN is blood indicated!

WHICH blood product should be used?"
HOW m'UCJi should be given?

--

2

CRAPTlm I
HISTORY

Blood, to ancient peoples, contained the essence of
the living being.

This fact determined the rational• of

their use of blood.

'fhe Greek idea of the four humors

was an exten�ion of this primitive concept; it was tha

basis of much of medieval medicine, and has been stamped
out only recently.
For in.stance, l[auritz. Hoffman (113), of Heidelberg,
in 1�67 taught that "in cases of melancholia, epilepsy.
and other hypochondriacal diseases, the cure iay in the
injection of the blood of a florid. youth into the veins
of the_patient. 11

The "florid youth" appears in many works

on transfusion of the time.

A.comprehensive list of

i.nd1cations
for blood was given by �ttmulier, a writer of
F
the same period (72).

•To correct a viai-0us condition of the blood,
To prolong the lives of the aged�
The cure of Melancholy delirium,
The eradication of Scurvy,
The cure of consumption,
The mitigation of arthriti8,
The removal of Epilepsy,
7he restitution of diminished strength, as weli
in the young weakened by disease aa in
the aged worn with years,
.For the alteration of habits of people of evil
disposition.
For the solution of calculi produced by a
tartarous state o{_ the blood.a
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Although several references to transfusions are found
prior to the latter half of the seventeenth century, it
was not succassfully employed before that time.

In tha

year that Jlauritz. Hoffman expounded his teachings, 166:7,
the first well authenticated transfusions were being given.
In London, Lower, after many successrul attempts on
animals, transfused a ]Ir. Arthur �oga, a nmild melanch&ly
insane man", who said that he found himself a new man

afterwar-da.

Lamb blood was used ·t1a2).

Denis, in Paris,

infused nine ounces of blood from the carotid arte�y of a
lamb into a boy of fifteen who was suffering from same
fever, and had undergone tw�nty venesections.

it is little·

wonder that a great improvement resulted.
Denis was almost cfill-victed. of murder fo],.lowing a
reaction in one of h�s patienta, a lunatic.· The .i'aculty
of Medicine of Paris� Denis• enemies, were influential

enough to obtain a decre� that transfusion ooul� not be
done without their permission, which was, in effect.
never.

(251}

After this, although there were a number of indi
viduals who did research on transfusion, and in some cases

made rather sensible suggestions, little interest was
aroused in the procedure until James Blundell (27). another
I

Londoner, attempted in 1818 to use transfusions in puerper�l

hemorrhage.

He began with a series �f experiments by

which he proved the feasibility of the operation in doge.
He devised an apparatus in which human blood was used.
Arter four unauccessrul transfusions in moribund patients.
he had five successes.

Great credit must be given Blundell

for the placing of blood transfusion on a scientific basis.
The increasing use of tranefusion was blocke.q � three

major difficulties:
agulation.

infection, incompatibility, and co

The l.a.st difficulty was partially overcome by

the use of defibrinated blood. first employed by Bischoff
(20) in 1835.

Anti-coagulant substances were -tried by

investigators with little success until the introduction
of sodium citrate almost simultaneously by Rustin of Bel
gium (117} and .Agote of Argentina (2} in 1914.
The difficulty of infection was eliminated by the
application of Lister's aseptic technique to the operation.
The remaining imp�diment of transfusion reaction was re
moved by the announcement by Landsteiner and his co-workers
(136} of th e blood groups in man.
However, stil1 another problem remained to be solved:
the actual technique of transfusion, which still at this
time involved a rather formidable operative procedure with
destruction of a vein or artery.

Many attempts were made

to overcome the difficulty..- and a gradual improvement was

5

effected.

In

1911, Curtis and David {55) devised a rela

tively simple instrument with the following advantages:
it was not necessary to cut down on arteries or veins; the
apparatus was completely closed, and acted by means of a
ball valve arrangement.

lt was _possible to measure accu

rately the amount of blood given.

It was possible to add

anti-coagulant as the blood was drawn.
Thus by the time of the outbreak of the first World
War, transfusion had become a safe, simple procedure, with
for the most part, rational indications.
Two great advances in technique have been developed
since 1930--the blood bank and plasma fractionation.
Although beginning attempts at the use of stored blood
were made during the first World W-ar. and in the Spanish
Civil War {158), its great perishability prevented its
use on any large scale.

During the present war, whole

blood is being flown to units in the field.
In large civilian hospitals, however, stored blood is
of even greater usefulness than fresh blood, since it
obviates the immediate necessity of procuring a donor. The
principle of the blood bank is familiar, and requires no
lengthy description.

Needed transfusion� are given from

the stored blood in the bank.; the blood -is replaced by a
donor, either professional or volunteer, whose type need

6

not be the same as the recipient.

In a large servioe. it

is expected that the numbers of each blood type of both
donors and recipients will be equal over a period of time.
The second reason for the popularity of the blood
·bank is the in.creased use of plasma which began with the
present war. Blood
stored over a certain
period of time
.
'
{usually given as nine days) cannot be employed because of
the increased frequency o! reactions.

However, if the

blood cells are separated from the plasma. the latter can
be stored and used; thus, blood that is nut utilized with
in the required period of time need not be discardad.
The logical extension of this idea occurred to certain
investigators.

Why not remove the red cells before they

became too ancient, resuspend them in saline, and give them
to anemic patients, who, as a rule, do not require the
proteins of the plasma?
Jrurthermore. plasma itself is composed of a number of
different constituents; if these could be separated, each
could be used in those conditions for which it is indicated,
allowing further economies, and making transfusion therapy
more a speciflc. than a shotgun affair.

This plasma protein

separation was accomplished by Cohn and his co-workers (48)

in 1940 by the =�ilibration of it across a membrane with
solutions of alaohol of controlled plf and salt concentration.
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Although methods for the isolation of various proteins by
preeipitation with concentrated salts, and by isoelectric
precipitation have been known for years, they are tedious
and not suited to work on large quantities of material.

Further description of these plasma fractions is to be
found in a second article by Cohn and others (49).

They

described each of the fractions in terms of all the physical
properties whic.h characteri�e colloidal substancas�

elec

trophoresis. sedimentation" osmotic pressure, diffusion,
viscosity, charge, and polarity.

Fibrinogen was found in

Fraction I� the globulins resided in Fractions II, III,
and IV, while Fraction V was fairly pure albumin.

Fraction

VI contained the residuals not precipitated.
Careful studies demonstrated that there was no signi
ficant alteration or denaturation of the proteins when
isolated by Cohn•s :procedures.

Further purification was

developed, and at the �resent time there are available in
large quantities. the following products of plasma frac
tionation:
1.
2�
3.
4.
5.
6.

Serum albumin. Not yet reieased for civilian use.
Immune globulins. These have been used clinic.aliy
in the treatment and prophylaxis of measles and
infections hepatitis.
Thrombin.
Fibrinogen.
Fibrin. These three products have been used in
in surgery.
lso-hemagglutinins. For blood typing.
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The investigation of produats of plasma fractionation
is still only beginning; great possibilities exist for
further development.
BLOOD SUBSTITUTES
It has already been noted that the pioneers of trans
fusion, Lower and Denis. used lamb's blood.

Following the

revi-val by Blundell·. human blood was u�ed generall-y in
transfusions ..

However, during the third quarter of the

nineteenth century, a wave of exaggerated enthusiasm occurred, and the indications were extended to inc.J.ude debili
tating diseases, especially tuberculosis, and burns. uremia,
syphilis, and insanity .•

Human donors were difficult to

find, and a number of authors, notably Gesselius and Hesse
advocated the use of lamb's blood.

The introduction of

sali�e in 1875 to 1880 caused a drop in the use of trans
fusion, and the procedure was virtually abandoned until
about 1900.

(251)

The tremendous increase in the use or- blood duripg
the World War led to the trial of many blood substitutes.
including horse plasma by Brodine and St. Girons (cited by
Ravitch and Blalock, 190}.
The expense and difficulty of obtaining human blood
has naturally led to intensive attem�ts to find an animal

source of supply.

Wangensteen and his group of workers
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have used bovine plasma in cases of cancer of the gast+oin
testinal tract, and proved that it was utilized to replen
ish body protein stores (133, 236).

As a human blood

substitute� bovine plasma is superior to that of the horse
because there are fewer reactions to it. (120)
Recently, plasma fractionation has been utilized to
There are strong indications that

produce bovine albumin.

bovine serum albumin which is free from all globulins will
not cause any reaotions (120).

Its physiologi�al action .

is the same as that of human albumin (62, 109).

Although

bovine albumin does not have as wide uses as blood, it
will undoubtedly become much more extensively employed than
human produ�ts for those conditions in which it is indicated

if these preliminary expectations are borne out� greater
experi.ence.
Striotly speaking, plasma� serum,

and

the products

of plasma fra�tionation are not blood substitutes, but
blood derivatives.
Since it is the colloidal properties of the adminis
tered fluid that are desired in the treatment of shock,
any innocuous colloidal material could ,be used a.s a blood
substitute in this condition.

The difficulty lies in find

ing a material that will cause no immediate or permanent
harm.
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Acacia solution was extensiYely used during the
first World War, but it has been abandoned.

Other solu

tions tried are gelatin, hemoglobin-Ringer t s, pectia.
isinglasa. methyl cellulose. and recently polyvinyl
alcohol.
The search for an adequate blood substitute ia still
in progress.
PilPARATIOliS

A brief description of the various preparations o.f

b,lood. and its derivatives is in order he.re.
l.

Whole blood:.

techniques.

This is obtained by a number

or·

It may be passed directly into the vein� o�

the. re-cipient (direct transfusion}, or may be stored in

a bottle with the addition of fifty cc. of sodium cit
rate to eae.h five hundred cc. of b.lood.

Suoh blood c.an

be stored for a period o:f time, usually given as eight
days, after which plasma or serum must be made from it.
A •dose" o� blood is 500 cc.
2.

Plasma:-

This is prepared. by centrifuging whole

blood or allowing it to settle, and then removing the
supernatant fluid from the oe-lls.

Plasma which is to be

shipped or which is to be stored for a long time is dried
by one of sevexal methods; the desi�cated product ia

-u.

reconstituted with sterile water before use.

By regu

lating the amount of fluid, a dilute. or concentrated
plasma can be preparad.

A unit of plasJDa is the plasma

obtained from 500 cc. of blood.
3.

Serum:

This is obtained when blood is allowed

to clot, and the supernatant fluid is taken oi'f.

The

actions of serum and plasma in the body are practically
identical.

According to a number of investigators, serum

causes frequent reactions.

For this reason, it has not

become as popular as plasma.· Lts greatest use is in the
prevention of infectious diseases.
4.

Purifi,ed albumin and glqbuli.1u

These are obtain

ed from pooled plasma by the fractionation method of aahn.
Albumin is furnished as the •standard· Army-Jiavy Pac1tage 11
of three ampules each containing 25 grams of pure pr0tein
in 100 cc. of buffered isotonic solution.
1:10,000 is added as preservative.
equivalent of 500 cc. of plasma.
. to heat and other influene:es.

Merthiolate

Each ampule is the
Albumin is very stable

Exposure to high (100 ° 'I/.)

temperatures may �ause the formation of a white precipi
tate; no reactions from the use of such a product has
been reported, and its efficacy is in no way impaired;
however� a filter is incorporated in the standar� package.
Globulins are ful'lni_a.hed in ampules ready for inj eeti on.
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5.

Resuspended }led Clell,a.;

of preparing these ..

There are several methods

Some allow the blood to settle, remove

the plasma, and use the cells; others centrifuge.

Some

investigators use the cell suspension as obtained from the
storage bottles, while othe:rs suspend it in saline solu.
tion.

According to Alt, and his gro�p (6} the cella should

be given within three days after the blood i� drawn.

A

five day period is satisfactory, although there ia marked
diminution in the survival time of the cells in the cu
culation.

A period this short necessitates eentriiugiDg.

Practically all investigators use the cells from one

liter of blood as one unit.

Reactions are lower than to

whole blood ..
6.

Bovine products.:

plas-ma and A,l.bumin:

Certain

British workers (66) have used bovine plasma a.fte� heat
ing to 70 ° C..

This. they �1aim, removes all the speci•�

specifi� s�batances; reactions are un�ornmon.

In thia

country. unmodified bovine plasma has been used experi�
mentally in c.ar-cinoma cases {133 .. 236].

Recently the

fractionation process of Cohn has been uaed to prepare
purified bovine albumin. which has been used with success
in shock and eypoprotainemia with virtually no raaoti•$
or ill effeets (62� 109).
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CHAPTER Il
C

SHO K:.

GENJt!BAL DISCUSSIQli

The moat important o:f all the indications
use of blood and its deriva tives is shock.

tor

the -

It is not the

purpose of this paper to go into the nature of shock- any
further than is necessary to ex�lain the rationale of the
use o:f blood in this �ondition.

Shock �s a compTex state, and it is diffieul.t to

establish a concise definition for it; the best that can
be done is to provide

a

description.

The alinical

pietura of shock varies according to the exact etiology
in the given case, but many features are common to all
forms.

The deso:ription given is adapted from Blalock {22a).

Sh�ck is genaraly classified into two types:

and secondary.

primary

Primary ,Sb.ock {11eurogenic, or vasodilator shock} is

caused� psychic or neurogenic stimuli which �aflexly
ca.use vasodilatiation, and hence a comparative insu!
fieiency of the blood volume.

Operations in the upper

abdominal region--stomach and biliary system---are the mo$t
likely to cause this.
irimary shock is usually transient, and little thera
py is indicated, outside o� general supporti�e measures.

However. other f.aotors"]]ay be present which lead to the
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development of secondary shock; the problem then ba�
comes more serious.
Primary shock is characteri�d by hypotension, warm
extremities, and normal or only slightly aocelerated
heart rate.

Secondary Shock fl:J.ematogenic, or vasoc.onstrictor

shock} is of more complicated etiology.

It is differ

entiated rrom primary shock by tachycardia, cold extrem

There

ities, and lack of re�ponse to supportive the.rapy.

is vasoconatriotion and a decrease in circulating blood
volume.

In the reiilB.inder o:f this paper, the term shock will.

refer to se�dary shock unless stated differently.
SYMPtOMA.TOLOGY O.F· SHOCK
General JY!Dl)toms�

The patient is weak and apathetic;

he may b-e irrational, ess,ecial].y

slowly ..

if tlie shock devel0-pa

Later, stupor and·uncons�iou.sness occ.ur.

The skin is at first pale, and

are usually ve.ry thirsty.

later ahows an ashen eyanosia.
mottled appearance may be noted�
perspiration is marke.d.

Patients

In depemdent portiORs a
Th� akin is cold. an4

Accord�ng to lilaloc.k.

synurome:-apathy. ashen e:yapo�i s t and cl.ammy

11

thi.s

$lea--��

so

eharacteriati<; that the diagnoeis ·or· shock c:an o:ften be

made at a glance. 11
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Cardiovascular symptoms:

'l.he pulee is rapid and

regul.ar. and small in volume, and may be imperceptibla.
'tarmaina.lly there may be irregular rhytbm.

bloQd pressure is low.

Arterial

In the early stagea systolic

pressure falls slightly, and the diastolic l)ressure rises;
thus th�a is a decrease in the pulse pressure.

Later�

both pressures deeline .. the systolic. more than the. dia
stolic. with further decrease in pulse pressure.

Accord.

i.ug to )[a.honey {l54} the deerease. in pulse pressure, and
the increase

in heart rate are much more valuable as

criteria of shock than is the systolic pressw:e alone.
Respiration:

Th.is rmdergoe.s little change rml.e.aa

there are a..sso�iated pulmonary conditions, as pneumoaia.
or atelectasia.

Dyspnea not due to one of thesa conditions

indicates that the circulatory disorder is due to cardiac
failure rather than shock.
Otb§r symptgms:

Gaatroin�estinal cemplaints are

uncommon in shock not due to a gastrointestinal condition�
Urine is decreased in amount p but has a low apee��ic
gravity; there is often an increase in the blood non
protein nitrogen.

These are secondary to changes in

kidney function �aused by hypotansion and anox1a.
Blood chemistry changes�

In addition to the above,

there is often a decrease in the alkali reserve of the
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blood, secolld�r-1 to d'iminishe.d circul.atten.

H.owaver. Ul

case£ with intestinal obstruction and vomiting, an in
crease may b� found.

Changes in the hematocrit, hemoglobin, re� count,

and plasma protai,Jt are of great importance and wili be
discusaed later.
ETIOLOGY AND ME-CHAN IS-JI& QF SliOOK

Shau may follow severe tEauma, hemorrhage, burna,
iuteatinal obstruction, ar toxemia.

There is no baais

foo: the separate c1aesification of h&morrhage and shock;

in both the same fundamental mechanisms operate, although
the detaiis differ.
3hock is primarily an aberration of the functiona

.of the capillary wall.

?his membrane i,s al.most imperme

able to collia<l mate�ials, unless it is damaged; it is
however,· freely permeable to dissolYed crystalloida and
gases.

The osmoti� pressure� the colloid material.a

(proteina) in th& blood stream: tends to hold fluid in the
vessels; sin�e· the capilluy membrane is permeable to the
cryetalloids� their osmotic presaura exerts no �ffect
wal.esa changing ra.PidI.y.

iiny 11rotein that happens to pass

through the cap_�llaxy membrane is returned via the l.YB).�
st�eam.

{Ko-on a 161}
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The exact mechanism of shoak depends on its etiolgy.
There are great differe:noea of opinion as to many of the

details.

?ha tollowi11g diseuaaion ia adapted from. Fre�

man (86) • adding to it the most import.ant thil oriea which
do not agree with his.
According to :Jreeman. initiating and sustaining
factoi:s muat be disting\liehed.
i lnitiati,ng tac:-tors:
A.

Fluid J.Osf t

Hemorrhage. dehydl:at;i.o!l., and.

massiTe exudation {burns. peritonitis}.

BlalocJt t a

theory of traumatic sho�k holds that the init�

ting mechanism is fluid loss into the trawaa.ti�d

area.

He atates that enough plasma is lost

locally in many �ases to account tort.he indue
tion of a shock state.
IL

shock.

{22a)

Primary i"jll & blood pressure t

Primary

As stated before ,. this condition rare.ly

passes _into sacondary shoc:-k., wuesa other eonui•
bu.ting £actors are present.
Cl.

Reflex vasoconstristion.

Trauma.ti�

stimuli may initiate �oak through a primary vaso•
constriotion, which cauaes a reduetion in the
blood volume.

n.

'.foxic states;__ Hiatamua. peptone � and
anaph,ylaxis. Koon ts the,ory of traumatic shock
18

holds that the initia� mecllaniu i.-�taxic

absorption or- aubs-taJ1.C1es produced by t�aama. to
the. tiss11ee (167).

The reaearchea of 0'$hs»xp:&&ay

and Slame (119} indicate that this substanee can
S-�der :re.-la tha� potassium

not be ·hi&tamine.

acts as the tox:i,.n {208al.

r1 &.lataining·fagtors:

Once one or more Gf tha

initiating fact_ors has begun the course o! aho.c.k. a set
of� sustaining :taetors is se.t into motion t.o maintain the
p,rocesa.

Since not all cases of shoek are fatal., even i:t

untreated. there must eXist compensati.Jlg faetors which
tend to counteraet the eycle.

The moat !Jnportant of' these

is found in hemGrr.h&ga after which fluids pass :from tha
ex.traceiiuar spaces into the blood vesgels t& maintaJ.n
the blood volume..

'?b.eae. companaati.ng :raetoxs have not

been thoroughly atudi&d...

To.e. cycle- of sWJta-inim.g :Cactora is beat presented

by means o:f a diagram...

(iig .. l, page 20}

:&xam:ining the vari&us

-y�\�r"f'•

of the diagram:
1.

Diminished blood flow:

beginn.ing at -the l.ei:t

The majerity o� th&

symptoms of shock are caused by __dim�ished blood flow ..
According to �eeman {86}. aad also Blalock (22a}. the
cardiac output diminishes bet.a.re the bloQd pressure does.
{
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Trauma to Tissues:
Physical
Chemical

. K
(Scudder}

Toxins:
Histamine
Peptone

{Moon)

/

Generalized Tissue
Anoxia.

/

l

Fliid Loss:
Hemorrhage
on
��;��!
\i

Generalized
Capillary ·
Permeabilit

/

.

(Blalock)

Loss of
Plasma

�
Decreased
Diminished
Segregation of
Red Cells
---ft1ood Volume
_Blood Flow ____.,..
enn,m,
Fine)
(:8r
\

Vasocon
striction,
Taehyeardia.
·•\Wwered Blood
Pressure

Prima�Shook:
Paye c
Reflex

Trauniatie
Stimuli:
Pain Fear Cold

Fig. 1. The Mechanism of Shock (adapted from Freeman, 86)
Lines and markings in red indicate disputed points.
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indiea.ting_ that the process

or

shock is fairly well

advanced before diminished blood pressure is noted.
Di.mi.Dished blood £low leads to sluggish flow in the

musQle capillaries� with "sequestration u of tha red
blood cells in those capillaries (171. 30}.

hr-thu..- in

hemorrhage F the red cells tend to become larg�r in size,
and this adds to the pro�ees (30}.
2.

Generalized tissue anaxia:

The decrease

in

peripheral �geaation leads to deranged funotion.

3-ince

the int.ac.tness of the capil.l� endothelium. depends. on
adequate oxygen, increa�ed permeability follows in all
the vassals of the body.
3.

Generalized capillary p&rmeahilitYt

Thi.a con

di.tion leads to the loss o'f: plasma protein f:rom the
capillaries into the tissue spaces.

Generally� this loss

is predominantly the smaller albumin molecules� as ia

proved by the fact that the total cireulating albumin

decreases more than does the total cireulatiag globulin
(14).

I.t should be noted that Fine and Seligman (79, 80)
have found from studies with radioactive proteins that
this generalized capillary permeability does not exist.
Their teahnique involved injection of sueh proteins
into .fU}imals which were then made to go into sho�k by
21

means of bleeding, burning, or tourniquet.

Tissue sam

ples corrected for the amount of blood in them demon
strated no appreciable differences between control ani
The

mals and animals in reversible or irreversible shock.
authors concluded from this and other evidence that

there was no generalixed capillary permeability in shock,
although in burn and traumatic shock, there is los� at
the site of the injury.

These authors postulated a mechanism of shock.

The

cause is progressive peripheral stagnation of cells,

combined with local plasma loss at the site of trauma
in traumatic and burn shoek.

This "trapping" of cells

the authors proved to exist by the use of radioactive

iron in red cells.
thus trapped.

About one-fiftp- of the blood becomes

The work of Brennan (30) and of Muirhead

and others (171) is in agreement.

The latter authors

found clinically that the red count and hematocrit of

capillary blood (from a finger) was higher than that of

venous blood in shock.
Fine and Seligman claim further that the blood vol

ume is not lowered in all forms of shock; for instance

in toxemic shock and shock due to severe infection, the

mechanism is almost solely that of progressive trapping
and stagnation.

If these results are correct, it will

be nec_essary to modify many of our generally accep·ted

ideas of shock.
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4.

Decreased blood volume:

of plasma� and ))y sequestration

This is caused by loss

or the red blood cells.

Blood. volume decreases before the blood prassure doas,
according to the studies o� .Mahoney.

{154}

All authorities agree that decreased blood vol�e is
the most important feature

o:r shock.. It is the point o:r

the shock cycle moat e.aail.y attacked by therapy.
5.

Lowered blood pressure:

decreased blood volume.

'?b.ia results from the,

It is a relatively, late oceur

ence becauae of compe�aatory vasoeonstrict-i.on.
6.

Vasoconetria.tion::

The sympathetic ac-ti vity aaao

aiated with vaaooonstric\ion ia the cause of the t-achy�
aardea

and

perspiration noted in shoek ..

'!'he -.rk o�

Freeman and hj..s group have demonstrated tbat while thia

proaess i.a beneficial at first in that- it maintains the
blood pressure, it later causes diminution er. the blood
flow and of the blood volume.

(85}

This completes the eye.le of the sustaining factors

o£ shock. as generally accepted.

Irreversible Shack
'lb.en the cycle of shock has operated to such an e+
tent that generalized eapillaxy permeability be�omes
JILaJ;'ked, any fluids giYen will__pass fapidly into the tissue

23

spaces even if there is a high eontent of colloidal
material.

Shock. is then said to have become irreversible.
BLOOD CHAliG..i!:S IN SHOCK

As mentioned before, the earlieet changes in shock
are a decrease iIJ blood flow and in blood v olume.

Ysthods

for the determination of these have not as yet come into
g�ne.ral clinical use.
Changes in the hemoglobin, hematoc.r�t. and red eount

are the moat commonly used blood indices of shock.
1.

Hemorrhagic shock:

The above values are decreased

due to transfer of fluids from the tissue spaces into the
blood stream.

The deqraase is not pronounced, howeYer.

In ahock with both hemorrhage {either internal or

extern.al} and traUBJ;a., the blood picture is confused, and
cannot be used to determine the type of shock or the state

of the eir�ulation.

This group probably includes the

majority of cases ealled "trauma.tic shock. 11 •

The increase ·1.n,volume of the red cells, noted by

Brennan (30}. further confuses the picture in hemorrhagic
2.

Shock with

!!_2

blood �:

The most important

form of this type &f shock is burn shoek, in which hemor
rhage may be virtually zero, and yet there may be enormous
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c-ontinued losses Qf pl,asma.

In burn shock, the blood

indices at any moment would then give a rairly accur_a.te

picture 0£ the amount or plasma lost.

A number of authors have attempted to use these blood

values in the calculation of blood volume and of the
amount of fluid to transfuse.

The formulae are ge»erally

simple, and will be discussed later.
lsFF..isC:TS OF NON-COLLOID� :i"LUIDS.

O!i THE COURS..& OF SHOCK
Besides colloidal fluids� saline and giuaoee are
c.omm.onl_y used in the therapy of shock.

Such treatment ,.

whil.e of extreme value, is not· without danger.

Beari

anci :S.1alock (1.4}, Rl.aloek, Bea.rd, and Thuss (23} ., and
Sharpey-Shaf�r and W-allace (210} have emphaeized that if
exeess quantities of crystalloids are given to a patient

in shock,. the total. amount of protein oi.rc-ulating in the
blood stream is lessened ., indieatlilg that protein 1s

washed f'rom the circulation by the fluid administered.
These solutions are of greatest value

ing situations:

{1) Prevention of shock.

in

the follow

Adequate f"luid reserves

are a great defense of the body against .shock. :from any
source.

(24 • 40 ,, 127, 139}
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(2} De_hydrated patients.
(3} C.oncentrate.d plasma therapy.

Fl.uida are a -very

necessary part of the therapy when concentrated plasma
or albumin are

used.

This

will

be

disc.usse.d lat-er.

{4} Inability of patient t� take fluid by mouth.
After the acu.te phaa� of shock is o:v:er. many burn patients
are unable to take fluida by mouth.
given by s.ome other- rout.e.

These must then b&

(ConkJ.ey _. J,.55)

SUliMARY

The mechanism of shock i�volvea a progressive fall
in eirculating plaama volume.

Th� earlier proper tharapy

ia begun. the less likely a state of irreversible shock
is to occur.

The present trend is tnward prevention

rather than treatm�nt.
To restore cireulating blood volume. fluids con

taining colloidal material must be given; otherwise. they
will not be retained within the vascu:Lar syste.m.

There

is atrong evidence to suggest th.at large quantities of
crystalloid fluids cause ·ioss of the vital protein col
loids.

Therefore, fluids such as saline or gluc.oae a ol-

u tion should not be relied upon to treat shock. nor should
excessive amounts be given along with colloid-oontaining
fluid.

26.

In the diagnosis of shock. systolic blood pressure
is. the most commonly used index.

1'xperimenta �ve shnn _.

hGwever. that it is altered relatively late, being main
tained by vasoconstrictor activity after the cardiac
output and blood irolume have already decrease:d.

Hor

these. reasons, a dec.re&si-ng pulse pressure. as suggested
by Blalock {22a} is. pro?S,bly a better index of early
shock than is the systolic pressure.
Blood determinations ► especially hemoglobin. hema�
tocrit. and red count are of greater value in burn shock
than in traumati.c or hemoxrhagi� shock.

In burn shock,.

the hemoeoncentration gives a rather accurate piet� of
the 0.4act status of the patient•s circulation.

2'1

CRAPT.E.R Ill
Tmi US:& OF .Bl,OOI> Di SROCK

Rl.ood and its derivatives are accapted as the most
important single item in th� treatment of shock.

Other

measures,.. i�ellidiag merphina. recSt. warmth. and fluids
are not to be neglected.
recommended

w

Adrenal cortical extracts are

some.
TB.AUJUTI.C! SHOCK

T:he tact that shock can best be treated -»y the use
of colloidal fluids was recognized during the first W:orld
ki-.

Aea.eia,. gelatin, and blood were wid-ely used. with

good succass 146-. 191:h 186).

Plaama was not used to any

significant extent,. -a1though Ward {238} suggested that it
ba used in casua1ty cleari•g stations.

In 191..9� Keith {127} did extensive studies on human
cases with determinat�on of the blood volume by means of
vital red.

lie tcund that the b-load and plasma volumes in

both h.emcrrhagie and tratllllatic shock ware consistently
reduce-a.�- and this r-eduotion bore a definite relationship
to the clini�l cond�-tion.

lie divided his cases into

three groups}.
.t:-..

C.Ondition ge>od; symptoms mild.

Pul.se 90-lOO-�

blood pressure �er 95 mm;, :}\lila:6-- pressure- usaally not
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decreased ..

In these oases the "t>lood voluma is greate.r

than 7 5� of normal.
II.

Condition serious; symptoms marked.

Puise. 120-

140. blood pressure lea� than 90 mm., usually 70-80 mm.

Pulse �reesure lowared ..
Ill..

120-1.60.

The blood volume i� 65 to 75$.

Condition grave ..

Pulse not felt, heart rate

Blood pressure l.ess than 6-0 mm..

The blood. vol

ume is leas than 65%.

In therapy. Keith held that the inereas� or blood.

volume was the important thing,.
acaoia best for this purpose.

He considered b.lood and

I.n some cases� fluids, by

mouth or reatum., and warrath were sufficient-.

Recovery was a1ways'accompanied by an increase in

the

hlood volume, whether or not colloidal agents we.re

giyen.
although

In cases of irreversible. shack, it was found that
large amounts o� fluid were given, the blood

volume rose only slightly.

The first investigator to teat the use of 1?_¥tsma. in

traumatic shock was Mann (159}, who treated shock �r_oduae�

by the exposure of the abdominal. viscera i:n experimental
animals.

Cryetalloid solutions produced only transitory

rise in blood pressure, while blood frequently restored
blood �essure_ after they had �ai�ed.
eally the same results as whole blood.
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Se.rum gave pra�ti�

In 1920. Whipple, Smith'" and Belt'{244l produced
shock by plasmaphe�esis--the withdrawal o� p1asma whil.e
retaining the red cells in the circulation; this shock

they succea&fully treated �y the re-introduotion of an
equivalent amount of serum.

Cannon, in his book on sho:ck (l9G3 J, reoomm.ande.d.

acacia or hlood� the latter in amounts of 500 to 750 ca.,
and more if "circ.wn.stances aeem to require it 11 •
was stated concerning the use of plasma.

Jiotl;Ling

(40}

Following this• experimental and e:lini.eal progress
in the study o.f the uee of blood and plasma in shoek was
very slight until 1931. and 1932, when Blalock and Beard·

(1.4, 231 rep.orted an extenaive aeries on blood aha:ngas in

shock pr-Odueed by continu.oU:S trauma to the intestine.a.

Untreated animals had a great decrease in plasma voluma
with little change in the coneentration of the plasma
proteins.

Tb.is e•ignified a. loss in the amount of e-ircu-

1.&ting protein ..

Analysis of the paritone.al exudate..

accounted for the loss.

The iAjection of various solutions showed the f'ollow-,
ing:

(a)- Saline and glucose caused a decrease in the total.

circulating proteins, indi�ating that such solutions
11

washed out 11 the. prot,ein from the oirc.ulation.
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(b} Se.rum injections were associated with only slight
ohar,.gea in the con�entrati6ll Qr protein and

in

blood

volume..

In

1936. Harkins (103) rev�ewed the use of plasma in

traumatic shock, and upheld the local plasma loss th•ory.
He atated that since the fluid lost was plasma rather than
· whole blood. the ideal therapy might be tha farmer.
kperimental &Tidenoe bore this out, but he aia.ted he had
no.t treated any cases with plasma..
In 1936, the drying processes for serum and plasma
were first developed.

In

1938, Bond and Wright (28) re

ported on the asa or lyophi.lized serum�

They stated that

dec,raased blood -volume wa.a the important featu�e of shock.
and that the best the.ra.py was to infuse blood.

But sin�&

blood may not always be available, the usa of plasma may
be �onvenient.

ln experiments on dogs, in which very

severe shoc.k was produc.ed by intestinal manipulation,
trauma, or repeated hemorrhage, controls all died.

llo

therapy was successful, although a.oaaia and lyoph.ili�e.d
serum brought back to its individual volume gave much
better results than arys-talloid solutions.
Also in 1938� Freeman and Wallace (87} studied tha
eff&ct of concentrated serum the.rap.y in shoe-le. and found

that it produ�ed an inc.rease iD the circulating blood.
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volume equivalent to the original volume of the serum.
evidently by attracting fluid in�o the blood stream.

ln the year 1938, lfahoney (154} used dr1-ed plaama.

which had been restored to the original volume of the.
blood,. and henoe was about 50% (or ½X} of the original.
concentration.

Sho�k produced by cooling tha pe.ri"toneum

caused a decrease in blood volwne and changes in the

blood findings as in the expe.riments of Beard and Rlal.ock.
B-lood caused a gradual increase in pressure to normal in
all but one animal.

Preserved p,lasma (½X) gave. the. same

result, but. the return to normal was more prompt.

Ha.w

ever. in ahoc:k produced by trauma to an extremity, rea
ponsa to plasm-a was temporary.

lfahoney conoluded that

plasma in traumatic and hemorrhagic shock is only o1' tem
porary value until blood can be procured.

lie also stated

that he had had some c.ltnioal exparience whiah he. did not
re.port.

The onset of the }:)resent. war caused a great inere:ase
in the use of blood and _plasma in shock,, and many reports
wexe made. beginning in 1940.

Beat and aolandt (16)-. in Canada. used 3.t serum in

dogs au.bjaeted to various forms of shook.
conc.entrated 'serum gave eJCcellent results.
in hematocrit and the...Jiilution
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of

In all casaa

The ina.rease

the plasma proteins

caused by shock, was reversed by this therapy.

Thea.&

authors advocated vaaoaonatrictor subatances, stating
that results were better with the:ir use.
Levinson and Rechel.es, of Chicago reported on the
use of serum in twenty-four shock patients, of whom six
teen suff�ed from hemorrhagic ahook, and seven from
shock without hemorrhage..

The amounts of serum given

varied from 450 to l40O cc.; all were helped, many dra
matically.

(l41, l42}

Hill, Mclichael, and Sharpey-Shafer (lil.} did blood
volume studies in shock.

Infusions. of saline into, nor

mal adults were lost rapidly .. whereas· 200 cc. or 4X serum.
caused an inerease in blood volume of

any increasa in blood pressure.
adminis.tration

aoo·

ec., witho�t

In eight cases o� shook

or serum, 4.Xgave good results.

Rrown and l[ollinaon (31} al.ao,reported on the. use of

4X serum.

In thirty-two oases of shock, th�r� was a

rapid rise in blo8d pressure on ad.ministration of serum;
most o! the rise occurred within ten minutes.

lialr the

patients showed a aignifieant slowing of the pulse (te.n

per minute}.

These authors emphasized the necessity tor

adequate dosage-not less than 100 cc. of 4X. serum { the.
equivalent of 400 cc. of normal serum) initially,. followed
by furthu transfusions as needed.
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In 1941� the articles on plasma a nd whole blood in
shock were more c1inioal in scope, the rationale of transfusion baying been firmly established by tb.at time.
l

Reports of the experience of various groups with p1aama
transfusion appeared.

11.ahoney, Kingsley, and Howl.and (156}

reported the use of pres�rved plasma in fourty..rour shoe-k
cases.

White, C.Ollins, and Weinstein. (245} in 194-1.

reported fi!ty cases 0£ shock. treated with plaama.
In the years .following 194_1 ,. more work has been q.one
on the exaet. me.ch.a.nisms of shock, and the manne..r in which
c:olloidal materials aat in producing rec.ovary.

Much w�k

has been done also in comparing the relative ad�ntagea

of partioular p:lasma preparations and 0£ a numbe.r of blo�

substitutea--gelatin, and hemoglobin Ringer's. espe._cia.lly.
A signifieant articl.e appeared in 1944 by :&vans,

Jame.a. and Hoover (74}.

They repeated the work of Kaith

on blood vol.ume relationships in humans during $hock. us
ing the :&vans blue dye, which gives more satis.factory
result.s than doe.s vital red.

Their. :patients were. mostly

compound leg fracture cases.

They confirmed the rela,tion

ship between blood volume and clinioal seve.rity ot shock..

However. their findings indicated that the loss of blood
volume and the amount of plasma necessary to bring th.a
patient out of shock show no definite correlation.
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For

instance, some of the patients had plas� volumes close
to 25

e-c../q.

{norma.l:

45 ec./kg.}; yet only 250 cc. of

p-lasma or 500 ce-.. of whola hlood brought about a aigai
fieant rise in blood pressure and re�overy from ah.oak.
However. following ree-o-we.ry. the balance. of the blood
pressure ·.ttis precario:us. as � proved by the fact._ that
sometimes changes in the position of patients. :Just reoo-v
e.red from shoe-k may pree.ipi tat& sudden d�th.

J'ollowiJl&

the 1mme;diate recovery !ram rahoek, the blood. volume re.
mains at low lave ls for as long as four days.

When the

increase in blood volume :finally occurs� there ia a por
portional. increase in the total c.irculating protein&.
Dilute and Concentrated
Plasma
in Trauma.ti� Shock
Following the introduction of the various dry:illg
�roaessas. it was posaibLe. by using diffexent amount&

ot dilu�ing agents. to prepare plasma or aerum o:t any
desired c.one:entration.

A. numbar of aa.thora tested thee

value: ,or· aoncEU\tra�$l<l. RlAIN

in

alltok,

Thia substance

has eertain technical. advantagaa. e-ape�i,all.J' spaad cf•
administration as wall. as oonvenienc.e in tra.nsportaticm;
henc.e if it could be used in pl.aee of ordinarJ pl.asma.
much wou1d be gained.

35

The work o� :freeman and Wallace (87), Best and
Solandt (16}. Hill, :VCMichael, and Sharpey-shafer (lll).
and Brovm and Mollins.on {31) bas been mentioned .before. ..
All these investigators found concentrated plasma or
serum to be adequate in the treatment of shock.
Certain authors made investigations far the apeeif'Le

purpose of determining the reiative advantages of dilute
and concentrated plasma.
Hill ,- liuirhe.ad • Ashworth ,. and Tigertt (11.2} ,_ 19,41,

and. Hill (1.72}, 1942, reported several series

and lw.irhead

totaling 13,8 cases in which 4X plasma was used.
depended on

The dose_

the response; an initial dosa of 100 cc. was

followed by similar

doaes as indicated.

. ..
gi.ven rapidly, often in a f'ew minutea

The plasma was
'They stated that.

the.re are three. contraindications to the use o� concen
trated

plasma::

my�dia.l

damage > c:ardi.ac decoml)ensati-on,

and debyd.ra.tion appraaohing ten par cent o� the bocl.Y

weight.

In the latter o.ase ,- f'luida may b.e given by any available.
ro•ute.

These

prevention of

goad results.
li.0-t all

authors also used c.oncentrated plasma in the
shock in thirty-four additional. cases w,ith

investigators agreed that concentrated p,l.aa:ma.

was the most ef'fective �arm o� therapy.

Ma.honey, Iq.ngaley,

. mpare
and Howiand {l.57} puf'ormed ca.rjl.f'Ul experiments to co

the n.lue of eoncentrated (4.X}; normal.. an� dilute (-SX)
plasma.

Shoc.k was produced by intesti. aal trauma..

Pro

phy1acti.e injection consisting Elf uitraven0ue therapy
beginning at the ti.me of trauma. prevented shoe�; an in

itial :ra.ll in blood. pressure occurred, but. !iJf.ab,iliza.tion

occurred at a point.: above shock leve::ls.

After- the de.

velopmen t of shock, treatment was begun when th� presaure
rea ched 80 mm.

l\l.ormal plasma showed temporary benefit.

Half-strength plasma, in 700 cc. d·oses raised the blood

voiume to normal, and decrea.&ed the hematocrit.

However.

concentrated plasma, in amounta of 200 cc •• showed no
appreciable e.ff.ect on the ar�erial pressure.

There was a

decrease. o:f 50% in the plasma volume, and an inere.a.se in

plasma protei
. na.

Conoentra�ed piasma waa of benefit ir

saline. were given first. and t hen after the blood pre�

sure had dropped to sliock levels, inf'usi.on:were begun.
The authors remarked, •The idea that concentrated plasm&
wili draw fluid from the tissues is invalid unless there
is. fluid to be drawn. 11

Tb.e..y stated, however, that in moat

elinieal cases. shock patients are rather well bydratad.
LateJ: work on concentrated albumin aolutions confirmed

these. results.

3'l

Discus.aion and Slnnmary
In �uroJDary. _it may be stated that. although plasaa

was suggested during the firat World War, it has only
recently come into general uae�

'.the earlier authors advo

cated pl.asma some.what apologetieall.y-.

Soon .. however, it

was discoYe.red that plasma was at l9-ast �-s effactiYe as
blood in the therapy of traumatie ahock, and at the- p�esent time, it is more extensively used than blood in this
condition.
eoncentrated pl.asma. has- been proved to be_ as valu
able. in traumatic shock as normal plasma, .PJ:0Vided proper
attention i.s paid to the fl.uid balanc.e o.f the body.
H&MORRHAGIC SHOCK
Since the time of Blundell, blood has been accepted
treatment in ·hemorrhage. During the period of the first
World War, the use of plasma in this condition was first
b,eing advo.cated.
Rous and Wilson (203), in 1918 reviewed the status
of blood and its substitutes at that time.

They did

experiments which proved that the red celis of a rabbit

can b.e. remo¥ed with l.ittle apparent effect i.:C the plasma

were replaced, proYided that not more than 75% 0£ the
cell.a were removed.

After this cxitical point, symptoms
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of acute anemia appear.

They concluded that the replaee

ment of red cells was not an important part of the therapy
of shock ..

To test fuJ:ther their hypothesis, they removed

rapi�ly one-half of the calculated blood Yolume from rab
bits, and repiaced it with various flui4s.

Rabbit plasma,

horse serum, acacia and gelatin caused rapid and sustained
restoration of the blood pressure. but Ringe-z- t a solution
gave only transient recovery; but if the animal. could live
for a half hour, it would survive.

One human case of

hemorrhage was treated with horse serum, with good results,
but the authors stated this was too dangerous.
Much of the work on plasma in hemorrhagi� shock was
done coincidentally with work on tral,lDlatlc shoek.

The

researches of Keith (127}, Bond and Wright (28), Levinson
and Necheles (142), and others have already been refe�red
to.

Other important experiments were as follows:
In 1940, Ma.gladery, Solandt, and Best (153) produced

e:x:peri.mental hemorrhagic shock by bleeding until the
blood pressure was reduced to 30 mm.

Blood and serum

were effective if 40$ of the blood volume withdrawn were
replaced.

The authors concluded from this that up to a

certain point, at least, ·replacement of volume was more
important than repiacement of oxygen-carrying power.
'.they found that concentrated serum was much less effectiva
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in hemorrhaga than was isotonic serum.

Rapid adminis

tration was preferable .._ and therapy should be begun early.

In the same year, Levinson, �euwelt and liechelas (141}
reported the use of serum in experimental hemorrhagic
shock..

&low bleedings were done, in which 80% cf the

calcuiated blood volume was removed in feur stages at
i.ntervais of half an hour.

Before

the next bleeding, a

volume of one of the fluids equal to that removed was re
placed.

blood or serum maintained thair

Dogs receiving

blood pressures and volumes well, whiie saline was inaffective.
Bu.ttle, K.ekwiek� and Schweitzer (38], in 1940 reported

RN" rapidly ,remQving 50% or the.

on p1asma. in hemorrhage.

calcul.ated blood volume of cats, the animals were reduced
to

a b-lood pressure l.ess than 60 mm. of mercury.

Untreated

animals died within one hou�; 11hile citrated blood in
amounts of 25 cc:/�.

plasma and serum.

ary eff-ects.

produce.d eom-plete recovery, as. did

Saline and �u-0ose caused only tempor

B.rennan (30). in 1940� stated that hemorrhage caused
an increase in the size of the red cells to 30 to 50% of
their original volume.

'?his� cOlllbined with the lowered

blood pressure, caused the cells to become side.tracked

in the muscle ca::pillari.es ..
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Plas.ma injections mobilized

these cells; hence they we.re, in effect., transfusion& of
the patient t s own blood.

In cases of hemorrh�io ahock,

treated with 500 ce. of normal plasma, the red blood.

count increased a.tter therapy-, and there was definite

clinieal improvement in all cases.
that the mean volume

o.t

Determinations showed

the oorpuseles had deereaaad.

:Levinson and his group (139, 1?5) in 1943 found that
d�dra:U-on lessened the response of hemerrhagic shook to
isotonic or concentrated aerum.

The concentrated serum

waa in:feriar to the dilute i.n su�h animals..

They stated

that for routine use, isotonic serwn and piasma were pre
ferable.
Not all workers found plasma ao fa:vorable in hemor
rhage._

B1ack and &'nith (22}, 1,.940, discussed the use of

plasma in alimentary hemorrbage.

:£hey ua-.e.d dilute plasma

(½XL and found that, although good results were obtained,

blood was b&tt�r.

�� stated that

!f��

the 1!-em�§l�bin is

less than 50$ of normal, plasma is eontrl&indi�ted.

They

cited the work of.Robertson and�. {i98}, 1918, who

noted that when the hemoglobin was reduced to below 40 to
5Qj.. the spontaneous blood dilution which follows hemor
rhage in the normal case, did not occur�

�t seemed that

the maintenance o:C- the hemogloba at this level was a-f
mare importance to the oi:g�sm than restoration
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or the

blood volume to full normal limits.

(198}

The United States Army Medical Department repor��
that many cases of hemorrhagic shock treated with plasma
relaps.ed into shock it: operated on with.out fl.lr'ther pre

paration.

%hey stated that plasma was uaed only to

affact immediate survival until the patient ean be brought
to an installation where faeilities for givini whole blood

are availabie.

{232)

lwre recently, much work has been done on the treat
ment Qf hemorrhagic shock� with concentrated human albumin
solutions; this will be dis,c:ussed la..ter.
ULCER .HJO{ORRHAG&.

?he statement is often heard that hemorrll,age troin

ulcers shoul.d net be treated by tra.nsf\laion.

Amc:mg the

authors that advised against transfusion in this--0ondition

are Bennett (15), 1925. '?Urner and von Briesen (228). 193'1.
Their rationale was that the increased blood pre$BUr�
which results from the transfusion may dislodge a elot,
and thus cause further bleeding.

Andresen (8}, -1927.

stated that no more than 150 to �00 cc. should ba given.
and these amounts with the greateat caution.

Only aftar

the end of the f!ret week could further trlUlafusions of

500 co. be given.

Apparently D-Olfe of these authors rep.,orted

any series of casas.
Thare are a great number of authorities who take the
opposite view.

In

1926. Keynes {128} reported 121 cases

of gastric and duodenal ulee.r hemorrhage, in which trans
fusions gave good results in 90, temporary benefit in
thirteen, and no benefit in eighteen�

lie stated that

transfusion prevents death ftom blood loss. and makes pos
sible an operation which would otharwise be contra•indi
cated.

He furthe.r remarked that the statement often

accepted that patients never die from ul.cer hemorrhage was
false.

The rise in b.lood pressure is not s.o great that it

will dislodge a thrombus, and blood promotes coagulation,
and hence should be of benefit.
'

1

other workers have extended th�ae observations.
Bastedo (13), in 1927 advocated transfusion, and warned
that it should be given early.

Polayes and Morrison (183l,

1932 ., used blood in 55 cases with good re11ults in 38.
Kordenat (132} reported faverably on a number of• cases,
and did expuimenta to prove that the rise in blood pres
sure would not dislodge a clot.

Allen (5}, 1937 • made the

oft-quoted statement, iew:e have seen patients die from the
lack of a transfusion, and in no instance have we s�en
transfusion responsible for fatal hemorrhage.•

Hartman

(106), 1939, advocated large amounts when indicated. stat-
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ing that one of his patients received twelve large trans
fusions in '12 hours, after whieh time it was deoided that

he was in satisfaetory condition for operation.

Ha st�tad

that the hemoglobin should be over forty per cent and the
red count over 2,000�000 before cparating.

Black and

Smith ( 22}-, 1940. eompared the use a£ blood and plasma in
ulcer hemorrha,ge and found blood sup�rior.
Gordon-Taylor {96). 1935,. gave rather det�it.e. indi
cations for transfusi.on in ulcer hemorrhage.

He stated

that in •v.ery patient with a pulae of 100 or �ver. and a
hemoglobin le.as than eighty per cent in a man or seventy

in a woman, a continuous drip transfusion should be bagun

at once.

rr

the transfusion doea not build up the hemo

globin properly ,. operation is indicated.

H.e stated that

the only danger rrom tranafusiona of this sort waa that

their success woul.d cause rel.uetance to ope.rate in caae.a

where surgary was otherwise indicated.
Srnm,nery

In hemorrhage. the replacement of oxygen carrying
capacity is, up to a certain point, not of great impor
tance.

�ce, plasma can be used with good results.

The

work of RobertfJ.Or.l and Boe:k indioatea that the dividing
line between hemorrage 1n which who�e blood is indicated
and that in which plaama �an be used is a hemoglobin of
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40 t.o 501, of' normal.

Blood must always be .con-side red

superior to plasma, if it ia available.
C0110entrate.d solutions of plasma can be used in

l;l.emorrhagie. ehoek if prop•� attention is pa.id to tiuicla ..
Blood transfuaion ia Rat contraindiaated in hemor

rhage from ulcers.

RORN SHQCI.C
One of the first to use trans.fusion in the treatment

or burn shock was L. :a. Robertson (193} who 1n 1921

studied its use in little childr�n

On th-e theory that

the shook. was due to a toxin_. he advoaa.ted "'exaanguina-ttan
transfusion•• _i:ll which l>loqd was withdrawn until there

were beginning signs of bloed. loss; transfusion was then
started, while contil'IUil'lg,-the bl-eed:j.ng.

Hi.ve. of hbt eases

recovered completely.

Davidson (58} in his classical article on the tannie

aeid treatment o� burns, us�d blood as part of the general
treatment.

In moat inatanc�s amounts of 500 cc.were used.

(1925}
One o£ the first investigators t� realize that there
is a decrease. in the blood volume in burn shock was Uadar
hill (22g}. 1927.

In spite of" the obse.rn.tion that plasma

loss is an important feature of shock > he advocated saline
and glucose in therapy without any mention of plasma.
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Probably the first 'to systematically test the use of
plaa1na in burns were Weiner, Rowlette, and Jilman (242),

who in 1936 noted the extensive loss of plasma into the
burned areas, and stated that this was the chief cause of
hemoconcentration in this condition.

In a series of forty

patients, many o:r
which had fatal burns, they noted very
r
high red cell counts in the presence of normal plasma
protein levels, a combination whieh indicated that plasma
loss had occurred.
Patie�ts treated with large amounts of saline or
glucose showed a fall. in plasma protein, but no change in
the level of hemoconcentration.

This indicated that there

was no change in the blood Yolume; the loss in protein

conc.entration c.ould only be due to a loss of protein :rrom

the blood stream.
developed edema.

Some of the cases treated this way

On the othe.r hand, treatment with acacia

or plasma rapidly reduced the blood count and decreased
the edema.

These authors emphasized the need for large

amounts of pl.aama, and stated that whole blood is not as
desirable because there is already a concentration of red
cells.

They further suggest the possibility that plasma

might aid the body in resistance to infection�r which .1..,s:;
a eommon complication in burn cases.
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laylor (220), in 1938, treated children suffering

from burns with amounts of blood which weuld correspond
to two 1£tars in an adult, roliowed by large amounts of
saline and glueose during the following two days.

Ha

noted no edema and no shock in his cases •
.lixtena'ive experimental work on burn shoek was done
in 1940 by Minot a.nd filaloek .(166).

'?hey

studied fl11id

balance, and confirmed the local loss of plasma that

occurs in this �ondition.

fhey also pointed out the

large amounts o:tplasma that might be r�quired..
About 1940, the war experience with plasm.a in bu�n .
shoc:k was beginning to be reported.

Black. .(21) reported

on the use of dilute and concentrated plasma.

Dilute

plasma (½X1 in amounts 0"f 50-0 to -2000 ac. gave more con
sistently successful resul.ts than concentrated {4.X.} in
amounts of 150 �4300 cc.
(see

below} for

required.

the

They introduced a formuia

c:aleulatian

of

the amount of pl.asma

They gave a routine of therapy;

1} Calculate blood Yolume deficit, and give this
amount of plasma while cleansing the burn.

After this

is completed. determine the hematocrit, and i� thia is
more than ten per oent above normal. plasma is again
given.

In the usual case, this procedure involves giv

ing one 11.ter

or plasma du.ring cleansin_g; and af.terwar-0.s

two to three iiters more.
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2) During the se�ond injection, watch for signs of
overdGaage; engor¥�ent of the ne�� veins is the most
valuable sign.
3) Intravenous therapy should not be mainta.iaed
more than twenty.four hours, in the uaual caaa, and never
more than forty-eight houra.
by other authQra have advocatad auch large amGtmts
for burns,, among them ·a.1man (68). rene-ry ,221), "iake!y

(233}. Mahoney and Howland (15�}. and Dunphy and Gibson

(63}.

The latter authors translated their exptrimental

results into clinical terms and stated that a seventy
kilogram man would require one to two hundred cc. 0£ plasma
per hour for ten hours for a severe burn.

That the.re is continuous loss of plasma was rec.og

nized by many of the above named author5.

The-duratioll

of this loss was put at thirty-one to forty hours by

Elkinton, Wolff ► and.Lee (67), from clinical data.

li.lman

.and Brown (69), from experimental work stated that per
meability rises to a maximum in thirty hours� and i�
not completely normal until seventy-two hours.

The lat

tar authors stated that single injections had only tem
porary effeet on plasma volume, the he�oconcentration
curve rapidly rising to the position it would have oc
cu�ied had no injection been given.

4.8

For this reason,

therapy must be continuous.
All the authors previously quoted based their judg

ment of the amount of plasma required on studies of the
blood.

Preaman, et. al. (185}, in 1943. stated that

ampunts calculated from the formulae in common uae were
too small.

They reported two cases in which the burn

involved about fifty per cent of the body sur�ace.

Both

received 1750 cc. of normal serum duri�� the first four
hours; during the next sixty-four hours, they manifested
a tenden�y toward hemo•onoentration, and reuired addi

tional transfusions to total amounts -Of 107 and 128 per
�ent of their calculated plasma volumes .(4250 cc. of
each).

Both also received large amounts

glucose ..

or saline and

The authors stated that any formula for calculation

of the amount of plasma to administer should depend on
the area of the body- surrace involved.

Hrorn these two

cases, and from others, they recommended that fifty ce.
of plasma be given immediately for each per cent of sur
face burned, followed by twenty to thirty cc. in 24
hours, and a similar amount in the succeeding 24 hours.
This is only a working dose; more should be given aa in•
dicated.

Saline and glucose are contraindicated unless

the patient is vomiting.

49

Local treatment should be

design_ed to minimize fluid loss:

eschar forming a.gen.ts

and pressure dress�s.
The fluid requirements of burn shock patients have
been studied.

Trusler, ljigoort, and \filliams (227},

advised against the practice· then employed (1939) ot
forc.ing water, fruit juices, and othe.r flu-ids on bum
cases because of the danger of water intoxication. a con
dition in whieh thare is intraaellula.r edema due to loss
of sodium and chloride from the body.

They cited con

vincing experimental and clinical evidence, and recom
mended saline solutions inst,ead of water. and plasma to
rep_lace the proteins.
C-oakley (155.) stated that following the stage of
acute shock the patient has a fiuid requirement of 4000
cc. par day,. which. in many cases, cannot be met. by oral
administration.

In injections, the patient's salt re

quirement shoul4 be furnished by saline solution, using

glucose to complete the total.
Hormulae for Calculating
Amounts of Plasma to be Used
As stated before, formulae are best used in .burn
shock because there is, in most cases. no los� of red
cells.

They may be used in...any form of shock in which
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it is certain that there has been no l-0as or· red cells.
The formulae fall into two groups: (l} those in which
the plasma loss is calculated from blood determinations,
and

(2)

those in which the amounts to give are calculated

from the area of the burn.
(1) Blood Index Determinations:

'.Phese formulae are

based on the fact that the blood volume may be computed

from the degree of hemoconcentration.

Their derivations

will not be given in this paper; the interested reader 1s
referred to the original artieles.
(a) Black (21), 1940:
which xis the plasma loss.

Hb (�n

100

%)

= . 5

S-x

, in

Tidy {226) suggested that this be modified so
that the normal hemoglobin does not appear: x • 5{;).eO.;.t)
y
in which y is the hemoblobin in percent, and x 1s the

fluid deficit to be replaced.
Black's formula solved for x.

Howner, this is merely

(b) Elkington, Wolff, and Lee (67) used an elaborate formula:

Protein deficit■ 3.5W - W(�(��Hi!)11!"

B0 1s the observed hematocrit;
� is the normal hematocrit.

P0 is the observed plasma protein level.

w

is the body weight in kilograms.
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The volume of plasma to be administered is de
termined by multi.plying the protein deficit by 14.
(c) A simple rule was advocated·by HaPkins (104):
For each point that the hematocrit is above 45%, 100 cc.
of plasma are to�• given.

The National Research Council

(176) advocated a-similar amount tor each point over 50%.
(d) Bushby, Kekwiok, end Whitby

(37)

stated

that if the various blood values were taken before and
after a transfusion of plasma, the blood volume could
be calculated by a f9rmu.la.

V •

, in which
•-··
xis the hemoglobin or hematocrit before, and y after
the transfusion, while Pis the volume of plasma trans
fused.
(2)

Area of Burn:

(a) The rule of Presman, et. al. (185) has al

ready been mentioned:

50 cc. at one�, and 40 to 60 cc.

in forty-eight hours for every percent of the body sur
face burned.
(b) The National Research Council (176) in ad

dition to the rule given above, stated that if a burn in
volves 10% of the body surface, 1000 cc. of plasma should
be given in the first twenty-four hours; ff it involves
20%, 2000 cc. shou1d be given.

(c) Newhouser and Lozner (174) advocated 100
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cc. in twenty-four hours for each percent of the body
burned up to a maximum of 4000 to 5000 cc.
diagram for the determination of areas.
as follows:

6%

Head
Both arms
Anterior
trunk
Posterior

18%
2�

trunk

Both thighs
Both legs
Both feet

They gave a

The amollll.ts a.J"e

(Both hands 4%)

18�
19%
1:3%

10��

The area of one palm is 1%; a fact which is of-

ten valuable in the rough estimation of areas.
Lund

and Browder

(147)

gave diagrams and tables

for estimation of relative areas in adults and children.

Their values for adults do not differ materially from those
of Newhouser and Lozner.

Children tend to have rela

tively larger heads and smaller extremitie.s; trunk area

peroentagea remain the same throughout life.
Discuaatpn

The emphasis of most authorities on the treatment
of burn shook has been upon the relatively enormous amounts
of plasma required.

As experience grew greatev, recom

mended doses of plasma grew larger, until, at the present
time, fairly accurate methods for the calculation of
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the quantities to give are available.

The warning of
I

Black (21) against overdosage has been replaced by state-

ments that it is impossible to give too much (155).

Most authors at the present time advise against intra
venous saline and glucose, preferring to wait until the

immediate crisis is over.

The chief value of the various formulae given is
that plasma requirements cannot be determined from the

blood pressure, which tends to be maintained until shock
is relatively fa:r advanced.

Since there are so many �ac

tors which may disturb the relationship of hemoconcentra
tion indices to the actual blood vo1um.e, the simplest

formula is probably sufficient, since none can be more
than approximate.

That of Harkins (104), 100 cc. of plasma

for each point the hematocrit is above 45% is the easiest
Such a formula must be applied

to remember and apply.

continuously; that is, determinations must be repeated

every few hours, and a sufficient amount of pla�ma given
each time until capil1ary permeability has returned to

normal, and there is no :further p1asma loss.

This period

is thirty to f'orty hours.
Lischer, Ebum and Davey (145) have noted that hemo
lysis_takes place in burns inflicted under certain con
ditions.

It is evident that such hemolysis will reduce

the hematocrit, and if a formula such as Harkins' is used
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the amount of plasma determined will be too small.
The observation that large burns require more plasma
than calculated (155) may arise from thta situation.
Formulae based on the area of the burn have the
advantage that the volume required can be known in ad
vance,, and that an accurate estimation can be made in
the absence of laborator7 facilities.

All the rules

advocated are almost equivalent, the simplest being,
"100 cc. in twenty-four hours for each percent ot the

surface burned".

Under B.nT circumstances, the clinical condition of
the patient should not be neglected, and if it is evi
dent that the calculated amount will be too small, more

must be given.

Rules, no matter how valuable, cannot

take the place of clinical judgment.
Local therapy of burns has been developed (not al

ways intentionally) in a direction to minimize the plasma

loss, both internal and external.

Eschar forming agents

and pressure dressings are generally advocated therapy.
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INTESTINAL OBSTRUCTION
The fourthtand final major type of snook is that
due to intestinal obstruction.
The first investigators to make a study or the plasma

volume in intestinal obstruction were Gendel and Fine
(91) 1n 1939.

They noted that doga with obstruction

died sooner 1!' there were distension than if there were

no�.

Thef

Strangulation caused

an even more rapid death.

found that such increased death �atea �orrespOnded

with progressive loss in blood volume,
that plasma would

and that,

They concluded

be indicated in intestinal obstruction,

while saline solution was valuable in therapy,

it was not vital.

In 1940, the same investigators (77) studied the

effects of' plasma transfusion. Tney aade the as8UJD.P.tion,

later discarded, that the plasma loss was caused by pres

sure en veins, forcing fluid 1n5Q the interstitial spaces

of the pelvis.

The loss was p

d not to be due to

loss of fluid either into the peritoneal cavity or the
lumen of the bowel.

Plasma transfusions in doge �1th

continued distension apparently were able to mainta1n
life indefinitely.

Saline was ineffective.

Fine, Fuchs, and Gendel (76) found that if the dis
tended bowel were decompressed, the plasma volume rose.
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They stated that clinically the condition or a patient
would vary from moment to· moment as the distension and
the resprption of 1n�estinal contents went en at dif
ferent rates.

Fine, Hurwitz, and Mark (78) studied the clinical

changes in obstruction, and demonstrated results similar
to those in animals.

'fhe relief at the obstruction by

appropriate measures caused a rise in the plasma
vo�ume.

They noted that distension of the colon or

gall bladder did not cause a loss ot plaBDl8. volume simi
lar to that seen when the em.all intestine was disten
ded.

None ot their patients required plaSDla.
Evans (73), 1943, studied str$.ngulat1on of the

bowel. and noted that after a time, when the capillary

permeability increased enough, there was loss of plasma
into the peritoneal cavity and the lumen of the bowel,
and that this lost plasma accounted for the loss in

blood volume yery closely.

The pet'itoneal fluid was

non-toxic on injection, disagreeing with the toxic
theory of shock in obstruction with stangul&tion.
Abbott, Kellors, and Kuntwyler (1) found that

in obstruction maintained tor several days, there
was loss of blood volume and of protein.

In summary, there is a decrease in blood volume
in distension of the bowel.
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The mechanism is unknown.

Besides this, there is loss of

piapia

into the perito"°

neal cavity and lumen of the bowel in strangulated
cases.

There have been no clinical studies on the use of

plasma in this condition.

Probably the delay involved

in the injection is not warranted, as relief of the
obstruction allows a rapid return of the plasma volume

to norm.al in cases without strangulation.

However, if

shock persists after proper means of deoompressi·on have
been instituted, �lasma is indicated.
Concerning the mechanism of the plasma loss in dis
tension of the bowel, there is a possible explanation

which is not, to the knowledge of the wr�ter, found in

the literature.

According to Koon (16?), the capillaries

of the small intestine form an exception to the general
rule that capillary walls are impermeable to pro·teins.
It is not, then, the colloid osmotic pressure ·that holds

the fluid in the blood stream in this region, but some

other mechanism.

In cases of distension, this mechanism

is deranged, and transudation of plasma takes place.

!he

exact nature of this mechanism is unexplained.This hypotb.Asis would explain most of the facts . re 
lated above concerning dilatation of the bowel.

Disten

sion of the colon does not cause loss of plasma because

the capillaries of the--eolon are not permeable to colloids
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as are the capillaries of the small intestine.

It

would also explain the rapid return to normal of the
plasma volume following any adequate decompr�ssion of
the intestine.
CONCENTRATED ALBUMIN IN SHOCK
The most recent development in the treatment of
the shock states is purifie4 serwn albumin, a prepara
tion not yet available outside of the armed forces.
Of the plasma proteina, albumin has the smallest

molecules, and thus exerts the �reatest osmotic pressure
per gram of substance.

It makes up only 60% or the plas

ma protein, but is responsible tor 80% of the colloidal

activity.· Hence 1.0 gm. of pure albumin should be equiva

lent to 1.2 gm. of plasma protein, or 20 cc. of plamna

of 6% protein concentration.

A unit of albumin bf 25

gm. is therefore equivalent to 500 cc. of plasma, in
terms of osmotic activity.
Phyaical chemical studies show that the amount of
fluid held in the blood stream by each gram of albumin
should be 18 cc.
Albumin is supplied as a 25% solution; hence it is

osmotioally equivalent

to a 5X concentrated plasma. Thus,

much of the discussion relative to the use of concen
trated plasma will apply to the use of albumin.
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There

is one important difference:

in concentrated plasma,

the electrolytes of the original plasma are concentrated;
while albumin is suspended in normal saline.
The first clinical repor� O!! lm£�f,!ed albumin was
that of Woodruf'f and Gibson (248), in 1942.

The original

plan was to teat the substance on one thousand cases

before releasing it for use; however, after only two hun_
dred cases, the results were so good that it was then

released.

It was tested in traumatic, post-operative,

and burn shock, and in shock associated with sepsis.

Results were poorest with the latter cases; but _many of
the patients showed some response.

The dosage used in

shock not due to burn• was one unit, .tollowed in fifteen
or twenty minutes by a second if the response seemed in-

adequate.

In burns, continued:.-doaea were needed. ·

It was advised that when large doses are to be given,

fluids should be administered by any available route.

The "Standard Army-Navy Package" of albumin carries,. a
warning to that effect printed on each can:

"PREO'AlJ'I'lON:

... -In the presence of dehydration, albumin must be ;g1-Yen
with or followed by additional fluids."

Heyl and Janeway

(110)

reported plasma volume studies

on normal volunteers who submitted to rapid venesection
of 15� of their blood, followed by inject�on of albumin
solution.

Such injection caused a fall in the hemato60

crit, and the blood volume rose an average of 18 cc. for
each gram of albumin injected, corresponding with sur�

prtsing accuracy with the theoretical value.

�

To test the effects of dehydration, food and fluids
were forbidden for fi-tteen hours before the bleeding of
one group, while another group was given salt and allowed
water as desired.

The immediate response to the albumin

was the same, but the blood volume was better sustained
in those who were well hydrated.

Girtng fluid allowed

the recovery of the blood volume in the dehydr•ted indi
viduals.
Janeway, Gibson, and others (121) have summarized

the question of fluid administration when using concen
trated albumin in the following words:

"Although the

administration 0£ concentrated albumin probably is not

harmful even in the presence of dehydration, for maximum
therapeutic effect, fluids should be given."
Heyl, Gibson, and Janeway (109) perfo•ed extensive
studies along the same line, using human and bovine al

bWnin.

Their results were similar.

average volume

They found that the

or fluid held in the blood stream by 1 gm.

of albumin was 17.4 cc., again a remarkable concurrence
with theory.

The bovine and human products had identical

properties in the treatment of shock; no

reactions or ill

effects were noted when the bovine albUmin was properly
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prepared; that is, free from globulins.
Cournand, Noble, and others (55) reported studies
on twelve patients with traumatic, hemorrhagic, and burn
shock.

The average increase in plasma volume for each

gram retained was 23 cc.

Warren, Stead, and Brannon (239) reported six cases

with similar results.

In their aeries, l gm. of albumin

was equivalent to 16 cc. of fluid.
In summary, the clinical and experimental studies
on concentrated albumin have shown that this preparation

is of equal value to plasma in the treatment of all kinds

of shock.

Advantages of albumin over concentrated plasma

listed by various authors are compactness, stability, and
low viscosity.
A possible objection to the use of albumin was men

tioned by Janeway, and others (121).

In burns, where

large amounts must sometimes be used, there is a possi
bility of decreasing the globulins, thus causing changes
in immunity and coagulation.

The authors stated that

nearly twice the calculated plasma volume can be replaced

with albumin and saline before signs of such globulin

deficiency will appear.
then be used.
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If desired, whole plasma could_

SUMMARY AND CONCLUSIONS
The mo8t accessible point to therapy in all forms
of shock is the diminished blood volume; therefore .whole
blood, p1asma -. Jserum_t and albumin are specific therapy.

The following may be swnmarized as indications for the
various derivatives.
l. Traumatic shock:

Blood, plasma, or albumin are

indieated in doses of one or more units, as determined

by �he clinical condition.

Plasma and albumin are superior,

but whole blood is sat��factory ••
2. Hemorrhagic shock: Blood, plasma, or albumin

are indicated in doses similar to above.
superior.

Whole blood is

If the hemoglobin is lower than 50% of normal,

plasma and albumin are contraindicated; whole blood should
be used.

3. Burn shock:

Plasm.a or albumin are indicated.

Blood may be used i� neither of these is available.
The amount is determined by the use of formulae (see p.
54).

All dosages are for adults.

In children, they should

be reduced in proportion to the body weight.
If albumin or concentrated plasma are used, proper
attention must be paid to fluid balance.

.given by any route available.
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Saline may be

Excess of saline or glucose solutions should be

avoided.

Since the use of ½X serum is rather well

established, a good general rule is that their volume
should not exceed the volume of normal plasma given
until the phase of acute shock is over.

Exceptions

are made when concentrated plasma is given, or when
the patient is dehydrated.

Blood or one of its products is not indicated
in shoe� from.�n intestinal obstruction unless it
persists after adequate measures for decompression have
been tried.

Then, the case may be handled much like

burn shock.
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CH/'cP'I'BH IV

EYPOPHO'l'EINEMIC STAThS
An important group of indications for the use of

blood and its derivatives consists of the hypoproteinemic
states.
Elman and Lischer (70}, in a review of the subject,
outlined the causes and symptoms of hypoproteinemia.
Causes include the following:
1. Malnutrition.
2. Protein loss:

Peritonitis, and intestinal

obstruction.
3. Nitrogen loss:

r.rhyroid disease, operations,

burns, and certain types of anesthesia (especially nitrous
oxide 2.nd ether).

The postoperative lowering of plasma

proteins has been stressed by a number of authors. (164,
43).

This lowering is featured by an excessive loss of

nitrogen, proving that there is a destruction of protein
rather than diminished synthesis.
gen takes place after burns (819).

A similar loss of nitro-

It has been shown

in experimental animals that after rhock due to hemorrhage
plasma :Jrotein replacement is slow (65).
4. Diminished protein synthesis:
5. Nephrosis:

Hepatic disease.

'lhis differs in many ways .from the

above types, and will be discussed separately.
'-if

65

'-'

The symptoms of hypoproteinemia are varied, and
depend upon how rapid the loss is.

Extremely acute loss

leads to shock, as in obstruction, burns, or peritonitis.
Less acute losses cause the following symptoms:
1. Suppression of urine.
2. Hemoconcentration.
3. Edema of the viscera.

This leads to varied

symptoms, such as distension of the abdomen and decreased
motility of the gastro-intestinal tract.

According to

Ravdin, Stengel, and Prushan:'..dn ( 189), the apparent failure of a gastroenterosto~y may be c~used by hypoproteinemia.

Postoperative

11

adynara.ic" ileus may also be due to

hy-:)oproteinemia in part, and the condi ticm has been successfully treated by plasma (Wangensteen, 235).
4. Somatic edema.

Tnis is a late manifestation.

It disappears only slowly after the proteins are restored
to normal.
5. Ascites.

Ascites is most marked in cirrhosis

of the liver, where a mechanical factor adds to the
hypoproteinemic tendency to edema.
6. Poor wound healing.

This very important feature

of hypoproteinemia has received emphasis from the work of
ThomJson and his group (223, 2B4), who found that wound
healing was delayed in hypoproteinemia, and that reinjec-
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tion of plasma restored the rate of healing to normal.
A great deal of study has been done on protein
metabolism.

Some of the important work includes the

proof b:i Holman, Mahoney, and Whipple ( 114) that protein
injections could be used by the body to maintain nitrogen balance.

Sachar, Horvitz, and Elman (204) showed

that there is a constant relationship between the plasma
protein (actual runounts, not concentration) and the
total store of the tissue protein, in which the tissue
protein amounts to about thirty times the plasma protein.
'This is a fact of extreme importance.

Daft, Robschei t-

Robbins, and •;~hipple (56) demonstrated that the tissue
cells could act as a depot for proteins, taking it up
when there was an excess, and releasing it into the blood
stre@n in case of demand.

PREOPERATIVE USE OF
BLOOD i~ND ITS DERIVATIV~S

Practically all the clinical work o~ the treatment
of hypoproteinemic states has been done in connection
with pre-operative correction.

Following a discussion of

this topic, the use of blood and its derivatives in nephrosis will be discussed.
i3efore the work of Thomson, Ravdin, and Frank ( 223,
224) in 1938, very little stress was laid upon the ade-
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quate preparation of patients for operation.

A few

workers reported unon oreoperative transfusions as important aids in the reduction of mortality and morbidity.
As a general rule, they stressed hemoglobin rather than
plasma protein.

Ward (23'7) .for example, advocated rou-

ine transfusion of 500 cc. of blood in all cases in which
the hemoglobin was less than 75;( of normal.

Cashman and

Baker (41a), 1936, recommended use of 1000 to 1200 cc. of
blood preoperatively if the hemoglobin was less than 50%
of normal.

The Mayo Clinic (148) reported a steady in•

crease in preoperative transfusions from 1935 to 1939,
indicating that the value was becoming recognized.
Plasma is an expensive method of restoring blood
protein.

Other methods, such as diet, injection of amino

acids or protein hydrolysates ("Amigen"), or feeding such
substances by mouth are much to be preferred.

These have

been reviewed by Elman and Lischer (69), Casten, Bodenheimer, and Barcham (43), and others.
The criteria used for hypoproteinemia have differed.
The borderline has varied from 6.C gm.7b (164) to 7.0
(199).

gm.%

The fact that dehydration may mask a low serum

protein has been brought out by m2ny of the authors cited.
Casten and Bodenheimer (43) stated that in most cases
dietary measures were sufficient; however in instances
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in which the mechanism of regenera_tion of plasma proteins
is impaired, plasma must be given.

They, as have all

investigators, stressed the need for large a.mounts, and
the temporary effect of single injections.

They esti-

mated that 500 cc. of plasma were equivalent to 0.2

gm.%

of plasma protein.
Robillard and Shapiro (199), in a detailed discussion
of patients with carcinoma of the colon and rectum, stated
that one liter of plasma is equivalent to 0.2

gm.%

of

plasma protein, and that if hepatic function were poor,
thj_s would be lost in twenty-four hours.

They also stressed

the correction of anemia pre-operatively.
Casten, Bodenheimer, and Barcham (43) stated that
a patient may heve a mormal plasme protein level which
is maintained only by the near exhaustion of the reserve
stores.

This is especially true of long illnesses, and

in cases with deficient or border-line diets.

Such pa-

tients should always be treated before operation in order
to build u:p the protein stores.

'rhey advised elso that

a patient whose plasma proteins were normal should be
given plasma during operation to prevent the post-operative
fall.
Binkley, et al. (18) found that in many cases of carcinoma of the colon, a satisfactory level of protein could
not be obtained by food or Amigen alone, due to low ability
~
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to synthesize proteins.

In these cases blood or plasma

were used, depending on whether or not there was an associated anemia.
Janeway, Gibson, and others (121) have used concentrated albumin solution in the trePtment of hynoproteinemie.

They found that large amounts !Jroduced only small

increases in protein levels.

The added protein was evi-

dently stored in the tissues, since there was no increase
in urinary nitrogen out::mt.
NEPHHOSIS
Nephrosis is a condition in which large quantities
of protein are lost through the kidney.

'.!:here are two

important types, ntrue 11 , or lipoid nephrosis, and the
nephrotic stage of nephritis.

Most of the symptoms are

due to the me_rked hypoproteinernia that results.
most prominent single symptom is edema.

'11he

Characteristic

is a loss of the osmotically powerful albumin molecules,
causing a revers2.l of the albumin to globulin ration to
a value less than one.

There is a decrease in the blood

volume (146, 241).

I1he use of concentrated serum in lipoid nephrosis has
been reported by Aldrich et. al.

They found that doses

of 50 to 80 cc. of concentrated (L\X) serum caused almost
immedia.te diuresis in the great majority of children with
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edema.

One case showed a loss of weight amounting to

005G of his normal weight in a perj_od of two weeks following two injections of 65 cc. each.

No case, however,

showed any significant ch2,nge in the plasma albumin level.
These investigators felt thE.t such results could not
be due to osmotic effects alone; there was some substance
which set off the patient's own mechanism of diuresis.
'.L'he authors noted that results were better jn early cases,
and thet single large doses were superior to many small
ones, even if the latter were given in a relatively short
time.

Furthermore, serum was ineffective in the presence

of any infection, such as a cold or acute exanthem.
The dosage used by fa_ldrich was 25 to 65 cc. of 4X
serum, depending on the size of the child, followed by
a similar dose in two or three days if no diuresis appeared.
l1he injection was repeated until response ocurred; accord-

1

ing to the authors, the maximum number needed was four.
This response was so invariable in lipoid nephrosis th~t
they considered failure a certain sign that the diagnosis
was in error. (3, 4)
Brown, Gray, and 1:iollison (32) studied ten cases,
of which eight were in the nepbrotic stage of nephritis,
one had lipoid nephrosis, and the last amyloid nephrosis.
Their results were disappointing.
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In all cases, there was

,_,
an increase in the total circulating protein which was
sustained for only twenty-four to forty-eight hours.
Otherwise, there seemed to be no significant effect.
Weech, Goettsch, and Lyttle (146) also did not obtain the good results of Aldrich.

Only one of their ten

cases responded to 70 cc. of 3X serum.

They noted that

in all cases there was a temporary hemodilution, indicating that the blood volume had increased.

'l'hey felt that

it was this increase in blood volume that caused the
diuresis, and to prove this, injected washed red cells
into a hypoproteinemic dog, and observed a similar diuresis.

However, they stated they could see no cause for

the fact that, although all patients had increases in the
blood volume, only one had diures::.s.

'Ihey noted that

that the advantage of concentrating the serum is slight,
2.nd since many nephrotic patients are a.nemic, whole blood
is indicated.
'l he
1

use of purified albumin nolutions in the treat-

ment of nephrosis has led to discouraging results.

1'he

most careful study of this has been made by Luetscher (241).
A single injection of 25 gm. of the substance, corresponding osmotically to 500 cc. of normal plasma, produced
only slight change in the plasma protein concentration in
young adults with ne9hrosis.

'-"
72

However, there was an in-

.._,
crease in the plasma volume, demonstrating that protein
was retained.

1'his retained prot.ein was smaller in

amount the.n the injected protein.

There was an ir:creased

loss from the kidney following the injection, and within
forty-eight hours the albumin had a;,parently disappeared
from the circulation.
DISCUSSION
'fue importance of hypoproteinemia in surgery has
become widely recognized, and most surgeons 1cow attempt
to better the general condition of the patient in this
and other respects wherever possible.

M.ost of the authors

who recommend plasma for the buil::iing up of the blood
proteins state that it is indicated only when the use
of high ~Jrotein diets and. intravenous or oral .Amigen
fails.

In most cases this condition arises when there is

liver dRmage sufficient to cause diminished protein synthesis.
The large amounts of protein required to raise the
plasma protein level by even small amounts has been
emphasized by all workers.

The reason for this is evi-

1

dent when one consicJers the fact that it takes 30 grmns
of protein to increase the amount of protein in the blood
stre2.m by only one e;ram.

,_,

Sachar and others (204) have

calculated on this be.sis that it
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11 eouires

756 gr2.ms of

.._,,

.

protein to raise the level of plasma protein 1.0
in a sixty ldlogram man.

n'm'-;1

r--.:_1.&u•

/0

This is the equivalent of

108 liters of plasma.
In lipoid nephrosis, the encouraging results of
Aldrich and his co-workers have not been repeated.
However, no author has employed concentrated serum in
the exact manner which he did.

In the other forms of

nephrosis, no good results have been noted.
SUMMARY

In hypoproteinemia, plasma should be used only as
a last resort, when other methods fail, or are not expected to help, as in cases of severe liver damage.
In nephrosis, although discouraging reports are in
the majority, concentrated serum is probably worth a
trial in cases of lipoid nephrosis. In other forms of
nephrosis, no favorable reports have been made, and
plasma is not indicated •

.._,,
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CHAPTER V

ANEMIA AND LEUKO?ENIA
All the indications for the use of blood or one of
its derivatives thus far mentioned are based on the use
of the various proteins therein contained.

The use of

the cellular elements of the blood will now be discussed.

ANEMIA
Anemia may be due to lack of iron or protein (nutritional), lack of the anti-anemia factor found in liver
(pernicious), destruction of blood cells (hemolytic),
depression of the blood forming organs (aplastic), or to
loss of blood (hemorrhagic).
In most cases of anemia, transfusion is not indicated.

when the cause is corrected, the blood will return

to normal.

Transfusion is indicated only when for one

reason or another, it is felt that there is no time to
wait for this return, or when there is an anemia of the
aplastic or hemolytic type for which no treatment is
known, or when the more usual measures fail to produce a
response.
Mariott and Kekwick (161) considered that transfusion
in ordinary correctible anemias is indicated when the
hemoglobin is less than 25% of normal, and in less severe
'W'
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anemias when some emergency, as an operation, exists.
They gave the following criteria:
1. Heme>_globin ~elo! 25tf.

al though 35J~ is a safe level.

Raise hemoglobin to 455;,
The average amount of

blood necessary is 2400 cc. in 38 hours, using a continuous slow infusion of blood by a technique they introduced
in 1936 ( loO) •
Other authors have advocated similar levels of
hemoglobin or red count as absolute indications for transfusion. For example:
Osgood and Ashworth (178):
Sodemann (212)
:
Forkner (82)

1,000,000 cells.
5 gm..;:; hemoglobin.
4 gm.% hemoglobin or
1,500,000 cells.

2. Hemoglobin over 25%, some em~g!=ffiCY:

Raise

hemoglobin to the lower limits of normal, about 80%.
The average amount needed is 2050 cc. in 25 hours.
3. Apl~~t~c a~emia:

Raise the hemoglobin to a lev-

el of 60 to 80%, and repeat the transfusion every time
the hemoglobin falls 10%.

Mariott and Kekwick believed

that such higher levels give the patient more comfort and
are no more difficult to maintain once reached.
A calculation from the data of .Mariott and Kekwick
(161) shows that on the average a rise of 1.8 gm. of

her:1.oglobin may be expected for each liter of blood in-
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jected.
The United States .Army at the present time recommends the use of 500 cc. of whole blood for each 3~ increase in the hematocrit desired.

No more than 1000 cc.

should be administered in twenty-four hours if the
hematocrit is less than 407a or more than 500 cc. if it
is over 40%.

The goal to be attained is 45%. (231)

There would be little advantage in discussing all
the authors who have recommended transfusion in the different forms of anemia.

A few of the special tyues will

be discussed briefly below.
The therapy of anemia by transfusion is mostly on a
basis of replacement.

The idea that transfusion gives a

nboost 11 to the hemopoietic system has been suggested (129,
p. 73), and is very plausible.

The increase in oxygen-

ation of the tissues and the relief of a great load from
the hemopoietic system probably enable a more rapid return to normal.
Special Forms of Anemia
1. Sp_p.eroc_-y:tic anemia:

a. Acute
hemolytic
anemia, or acquired hemolytic ic- - - - ---~--terus is characterized by spherocytosis, increased fragil~

•~-

ity, and hemolysis due to some circulating toxin.

~
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Accord-

._,
ing to Dameshek and Schwartz (57), who have written the
most recent complete report on the condition, transfusions
are usually, but not always of benefit.

Such benefit is

due to neutralization of the circulating toxin.

Josephs

(124) has attempted with some success to isolate this
substance from plasma, and has reported success in the
use of transfusion in this condition.
b. Familial hemolitic icterus is similar, but the
--~--

-

-
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spherocytosis is hereditary, and the condition is characterized by crises.

Splenectomy is curative.

Many authors

have recommended trensfusion; for example Gairdner (89)
has reported ten cases and stated that in eight, there
was improvement more rapid than would otherwise be found.
Recently, the high incidence of transfusion reactions
has been stressed by Sharpe and Davis {209).

Ihey recom-

mended caution in giving transfusion in this condition.
2.

Erythroblas~osis fetali~:
Erythroblastosis fetalis is a disease of the new-

born characterized by marked hemolytic anemia with a hjgh
percentage of erythroblasts in the circulation.
are three grades.

There

Hydrops fetalis is characterized by

edema and effusions into the serous cavities in addition
to the features noted above.

Icte~s ~ravis is present

at birth, or appears soon after.

.,.,,,,
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Jaundice is prominent.

._.,
Con~ni tal ~~_mi~ of the new- born is the mildest type;
jaundice is not present, or 1s very mild.
and erythroblastosis remain.

Only the anemia

Mortality is 80% in un-

treated cases, at least in the more severe forms. (93)
The cause of erythroblastosis has been established
in the last few years.

The disease is due to the presence

of a hereditary factor in the cells of the fetus (Rh factor) when that factor is not present in the cells of the
mother.

An escape of such cells into the mother's circu-

lation immunizes her and causes the production of antibodies (hemolysins) which pass into the circulation of
the fetus to produce hemolysis of its cells.

After birth

the child still has in its blood stream these circulating
antibodies.
rhe treatment is to supply red cells to the infant.

1

The majority of investigators advise the transfusion of
blood without the Rh factor (Rh negative).

This blood

will not be hemolyzed by the antibodies present, and will
sustain the child until the e.ntibodies have been eliminated.

F'or instance, Gimson ( 93) advised transfusions of

10 to 15 cc. per pound, and he found that no more than

two such injections were needed.
The blood of the mother should never be used even
though she is Rh negative, since it contains the hemo-

__,

lysins.
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Recently, the group at Washington University in
St. Louis has advocated the use of Rh positive blood in
order to fix the anti-Rh substances more rapidly.

They

have used concentrated red cell suspensions intraperitoneally with good results (90).

Successful results

with transfusion of Rh positive blood have also been
reported by Hutchins (118), although she recommended the
use of Rh negative blood whenever available.
Red Cell Suspens.ions
It has been estimated by various authors that half
the transfusions in a general hosJital are for the correction of anemia (6).

Since the majority of such pati-

ents have no need for plasma, a great saving of blood
would result if only the cells were used.

Red cell sus-

pensions have been used by a number of authors with responses about equal to those obtained when whole blood is
used.

Besides this, cell suspensions have a smaller vol-

ume, with consequently less danger of overloading the
circulation at a ti~e when the heart muscle has been weakened by anoxia over a long period (240).
'l'he first investigators to study the use of preserved

red cells were Rous and 'i'urner ( 202) who in 1916 found
that cell suspensions gave good results in rabbits when
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injected following hemorrhage.

Robertson (197) sugges-

ted the use of red blood cells suspended in gelatin solution for the treatment of shock; the efficacy of this
mixture probably depended more on the gelatin than on the
cells.
Castellanos and Riera (42), and Beu.mer and Schwartzer
(17) advocated suspended red cells in the years 1937 and
1939 respectively; but it was not until the beginning of

the present wa~, when plasma can1e into common use and
large quantities of red cells were being discarded, that
there was any impetus towards the study of possibilities
of use of suspensions.
In 1940, MacQuaide and Mollinson (151} used the cells
obtained from two pints of blood as none bottlen of cells.
They found that the hemoglobin was raised 10 to 15% (1.4
to 2.1 gm.%) by the procedure.
Watson (240) gave a convenient method for calculating the expected rise in hemoglobin.

The normal blood

volume in liters is taken at 1/11 of the weight in kilogrems, which is about 1/25 of the weight in pounds.

The

expected rise can then be computed by dividing the volume of the suspension by the normal blood volume, and
multiplying by the hemoglobin concentration of the susof
pens .~. . on 1 n gm.;o.
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The results of various authors in the use of cell
suspensions have been as follows.

Results have been re-

duced to the effect of the cells from one liter of blood.
Hemoelobin
MacQ,uaide and
Mollinson ( 151)

1.4-2.1_,
gm.1/o

Vdlliams and
Davie (246)

1.8

Cells

Hematocrit

. . .. . . .

.....
. ... .
.. . ..

. . . . .. .
. . .. . . .

Murray, Hale,
and ~harr (173)

2.0

Evans ( 73)

.. . .

Goodall (94)

1.5

480,000

3.5%

1.2

450,000

•••••

1.1

513,000

. .. ..

Alt, et. al.

(6)

Cooksey and
Horv!i tz ( 51)

5.87;

Practically all authors reported a lower incidence of
reactions than with whole blood.
lliUKOP.l:.:.:NIA

Leukapenia means Hlack of white cells 11 •

The leulrn-

penic states of clinical significance involve a lack of
tne granulocytes.

Such states are due to bone marrow dis-

turbance caused oy -coxins, poisons, or irradiation.

l'he

accepted treatment at the present time is the use of pentose nucleotide ( 11 Pentnucleotide 11 ) .

·l'his substance is a

product of the normal disintegration of white cells in
the -blood stream, and acts as a direct sti:-1ulant to the

.._,
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bone marrow.
'l'he symptoms of leukopenia cosist of a low resistance to infection, certain forms showing an especial
tendency to malignant ulcerations of the pharynx.
Blood has been advocated as a treatment of leukopenia.

Riddell (192) made the interesting suggestion

that the donor be given pentose nucleotide to raise his
white count before the transfusion is given.

The use

of lukemic blood has been recommended, but Witts (247)
noted that since lukemia in certain experimental animals
can be transmitted by injection of blood, the procedure
might be dangerous.
Strumia (217) suggested that 100 to 150 cc. of blood
be centrifuged and the leukocyte layer, which is found
just above the packed red cells be removed and injected
intramuscularly.

He found that i:::ijection of this "leuko-

cyte cream" caused a rise in the white count within fortyeight hours.

He believed that the brealcdown products

of the leukocyte cream caused a maturation of cells already present rather than an actual production of new
cells.

Later work of Jackson and

'1 ighe
1

(123) indicated

that this procedure was slightly better than the use of
pentose nucleotide, althcugh the series was too small to
prove this conclusively.

'-'
83

'w'

The most authoritative reports on transfusion indicate that its value is small compared to that of the
pentose nucleotides.

Doan (60) stated that with general

non-specific treatment, the mortality is 78%; with blood
alone, 64%; whereas with nucleotide, it is only 25%.

He

felt that the value of transfusion lay solely in the nucleotides contained in the. blood.
Jackson and Parker (122) felt that transfusions were
of no value, and th2t sometimes the white count was lower after transfusion than it was before.

Jackson and

Tighe (123) in 1939 wrote a careful article reviewing 390
cases of leukopenia found in the literature up to that
time.

They tabulated results as follows:
Mortality:

Treatment:

78%
None.
60
Transfusion, all cases.
82
Alone.
With other therapy, all
53
types.
With other therapy, ex74
clusive of nucleotide.
Pentose nucleotide alone.
29

Thus, if blood and other therapy not including
nucleotide are used, the mortality is reduced only 4%,
a value with little significance.
SUMMARY
Anemia is the most frequent indication for blood
\wl
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transfusion.

It is used (a) when the anemia is so

severe as to be dangerous of its elf ( below 257b hemoglobin), (b) when the anemia is severe and an operation
is contemplated, (c) in aplastic anemias, in which transfusions are used to keep the patient alive in the hope
that his hemaapoietic system will recover, and (d) in
certain hemolytic anemias.
Of the hemolytic anemias, erythroblastosis is treated
by the administration of Rh negative blood.

Probably

Rh positive blood is of equal value if administered
intraperitoneally, but its status is not yet established.
In acute hemolytic anemia (acquired hemolytic icterus),
transfusion is of great value.

There is evidence that

plasma may also be of value.
In familial hemolytic icterus, transfusion has been
used in preparation for splenectomy, which is specific
therapy.

The high incidence of reactions makes caution

necessary.
Concentrated cell suspensions are as effective as
whole blood, and reactions are fewer.
A liter of blood or the cells derived from it may
be expected to raise the hemoglobln about 1.5

gm.%.

Blood transfusions are not indicatec in leukopenia
since specific therapy is much more effective.
'w
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CHAPTER VI

HEMORHHAGIC STAT~S
Hemorrhagic states may be due to changes in the
capillary walls or to changes in the blood clotting mechanism.

Only the latter will be discussed.

of blood clotting is briefly, as follows:

The mechanism
Four substan-

ces are involved; (1) Prothrombin, which is produced in
the liver.

Vitamin K is an essential to its manufacture.

(2) Thromboplastin, which is derived from the breakdown
of platelets, or from the tissues. {3) Calcium. (4)
Fibrinogen, a protein made in the liver.

The thrombo-

plastin and prothrombin react in the presence of calcium
to form throrebin, an enzyme, which then acts on the fibrinogen to change it into fibrin.

The fibri.n clot is then

caused to retract by the presence of platelets.
Clinical aberrations of the clotting mechanism may
be due to changes in the platelets, lack of prothrombin,
or lack of finrinogen.

Lack of calcium severe enough to

cause hemorrhage probably does not exist.

PLAThLET CHANGES
Platelets may be absent or diminished in number
(thrombocytopenia), or abnormally stable {hemophilia).
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Thrombocytopenia
'rhrombocytopenia leads to the purpuras, with hemorrhages into the skin and mucous membranes.

Larrabee (138)

reported on the treatment of this condition with transfusions.

He stated that only direct transfusions with

uncitrated blood should be used, since the platelets
tend to stick to glassware and to filtering devices.
Usually several injections are needed to bring the platelet count of the patient back to normal; the aim of the
therapy is to tide the patient over until a spontaneous
remission can occur.

Fowler (83) reported good results

in 160 cases except when the lack of platelets was due
to leukemia or was associated with aplastic anemia, in
which cases such spontaneous remissions could not occur.
Hemophilia
Hemophilia is a hereditary disease, transmitted as
a sex-linked recessive; hence only males are affected.
There is a tendency to massive hemorrhage after relatively minor trauma or surgery.

The clotting time is prolonged,

but the bleeding time is normal.

The defect is generally

thought to be an abnormal stability of the platelets.
Transfusions are effective in temporarily lowering
the clotting time to normal.
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Birch (19), in 1933, advised

W'

blood either intravenously or intramuscularly.

Osgood

and Ashworth (178) advocated routine transfusions before
any operation, no matter how minor.

Many other authors

have made similar recownendations.
The mechanism of the beneficial effect of blood is
unknown.

Patek and Taylor (181) believed that in addition

to the abnormality of the platelets, there is some change
in the prothrombin in hemophilia, and that normal prothrombin will accelerate the clotting of hemophilic blood.
HYPOPR0 rHRO:t,1BINl!.MIA
1

Lack of prothrombin may be due to (a) Vitamin K
diflciency--hemorrhagic disease of the new-born.

Vi tarnin

K is synthesized by the bacteria of the intestinal tract
from substances very com1aon in food; hence the new born
child has only the store of the vitamin derived from its
mother until bacteria can become established in its intestines to produce its own •
(b) Paulty absorption of vitamin K.

Vitamin K is

a fat-soluble vitamin, and bile is necessary for its absorption.

Biliary fistulae or obstructive jaundice can

cause lack of prothrombin due to faulty absorption.

Sprue

causes a similar condition.
{c) Liver damage:

Sever~liver damage may cause bleed-

..._,,
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ing from ls.ck of synthesis of prothrombin.
(d) Administration of drugs which antagonize the
action of prothrombin, as

11

Dicoumarol 11 ••

The accepted therapy at the present time in all
hypoprothrombinemi.as is the administration of vitamin K,
although in the oresence of liver damage, it may be
ineffective.

Blood is of value in these states only be-

cause of its content of prothrombin.
The first report on the use of transfusion in hemorrhagic disease of the newborn (melena neonatorum) was
by Lambert (135) in 1908.

In his report, he mentioned

the "newspaper notoriety" which the case received.

The

child received a direct transfusion from the radial
artery of the father into the popliteal vein of the child.
The hemorrhagic tendency of the infant immediately ceased,
and the ~ound on the leg, which up to then had been
oozing blood, rapidly clotted.
Since that time, a number of reports have appeared.
Capon (411 studied 61 cases.

He stated that the mildest

cases needed no treatment; average cases should be given
intrB.muscular blood; but severe cases required intravenous
injection in doses of about 80 cc.

He was not certain,

however, whether the transfusion had a specific effect,
or ,,,hether it merely tided the ch:: ld over until the dis~
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ease stopped of itself.
'rhe fact that jaundiced patients have a higher
operative mortality than others has long been recognized.
Successful use of transfusion has been recorded most
recently by Judd, and others (125), who reduced mortality
from 4.3% to 0.97%.

However, they believed that the

mechanism was an increase in the oxygen carrying capacity
of the blood.

Walters (234), in 1940, recommended

vitamin K as prophylaxis against hemorrhage in jaundice;
however, if bleeding occur•red in spite of its use, transfusion was indicated,to combat shock and to give a temporary supply of prothrombin, whjch would last for six to
ten hours.
Fresh blood should be used for transfusion in hypoprothrombinemia, since there is a rapid decrease in the
prothrombin content of bank blood.

Rhoads and Panzer

(191) found that blood only three days old is of very

little use; blood stored a week is absolutely without
vs.lue.
'lbe hemorrha 0 e associated with the administration
of Dicoumarol can be controlled by the use of 300 to
600 cc. of blood, according to Meyer and others (163)

who did the pioneer work on the use of this substance.

W'
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FIBRINOGENOPENIA
The fibrlnogen of the blood may be low because of
poor nutrition, or severe liver damage.

Lack of fibrino-

gen is of little importance as a cause of bleeding; according to Quick (150) the fibrinogen may be reduced to
levels only one tenth of normal without serious effect on
the clotting of blood.
Congenital fibrinogenopenia has been reported. (150)
.Macfarlane I s case w2.s a boy whose blood failed to show the
slightest evidence of fibrinogen; yet he reached the age
of eight years before an uncontrollable hemorrhage apneared;
and from the report of the case, it is probable that
this episode was e.ssocisted v:i th a tran::J:!. tory lack of
platelets.

The

heredity

in the case was the-t of a re-

cessive, since the patient's parents were cousins.
FUNCTIONAL UTERINE BLEEDING
According to a number of German authors cited by
Kilduffe and DeBakey (129, p. 56), blood transfusions
are of value in functional uterine bleeding.
ism is not explained •
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SUM.MARY

In hemorrhagic states due to thrombocytopenia, blood
is of value.

In hemophilia, the only therapy that has given consistently good results is blood transfusion, which should
be employed to stop hemorrhage and should be used prophylactically before surgery.
Hypoprothrombinemias are best treated by the ad.ministration of vitamin K.

However, in those cases associ-

ated 'Hi th severe liver damage and in those cases in which
hemorrhage is progressing, blood sbould be given.
Fibrinogenopenia is probably not of much significance in hemorrhage.

If it exists, it could probably

be treated by the administration of blood or of pure
fibrinogen prepared by plasma fractionation.
Functional uterine hemorrhage has been treated successfully by transfusion.
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CHAPTER VII
INFECTION
Infections, acute or chronic, may lead to anemia
or hypoproteinemia.

~ither of these conditions may be

an indication for a transfusion.
However, in addition to such general indications,
blood is often useful for its content of antibodies
against certain diseases.

Such antibodies can be ob-

tained from various types of individuals.
1. Persons who have recently recovered from the
disease (convalescent donors).
2. Persons who had the disease a number of years
before (immune donors).

Such persons may be re-exposed

in order to build up their immunity still further (hyperinmrune donors).
Since the great majority of normal persons are
immune to certain diseases, such as measles, mumps, and
others, pooled plasma contains large quantities of antibodies.

The purified globulin fraction of such plasma

has been found to contain potent anti-measles and antiinfectious hepatitis substances.
3. Persons injected with infectious agents to
build up an artificial iumru.nity.
called i:mmunotransfusion.
._,.,;
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Such a procedure is

The agent injected may be

..,,..,
the bacterium. with which the patient is infected (specific immunotransfusion), or it may be a different organism injected with the idea of building up non-specific
innnunity (non-specific immunotransfusion).

Although

immunotransfusion is the basis of the use of animal sera,
the procedure in humans has not been used to any great
extent.
The various diseases discussed in this section will
be arranged in alphabetical order.

Only those conditions

of interest of importance will be mentioned.
BRUCELLOSIS
Several reports have appeared on the treatment of
brucellosis with transfusion.
recorded two cases.

Creswell and Wallace (54)

Both received 500 cc. of blood from

donors who had been selected for their high levels of
opsonins against the organisms.

One had a reaction of

chills and fever, following which recovery began.

The

other case had an immediate response, his temperature
dropping in a few hours •
Poston and Menefee (184) reported a single case of severe undulant fever transfused with 250 cc. of citrated
blood from a known immune donor.

Within twenty-four hours,

the temperature began to fall, and was normal in four days.
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On the ninth day following the transfusion, agglutinins
appeared in the patient's blood for the first time.
Such reports as these are difficult to evaluate because of the tendency of the disease to spontaneous remission.
DIPHTHBHIA
Few reports on the use of transfusion in diphtheria
have appeared, because of the great efficacy of serum
treatment.

Harding (102), from experimental work, found

that the severe toxemic stage of diphtheria resembles
shock, and advocated transfusion in the treatment.

She

advised 160 cc. of blood for a child of one year and
larger doses for older children up to a dose of 400 cc.
for a six year old.

No clinical reports have appeared

to follow up this suggestion.
ENDOCARDITIS
hndocarditis is a disease in which vegetations composed of fibrin and bacterial colonies (usually alphahemolytic streptococci) appear on the heart valves.

For

the most part, it does not appear: on healthy valves, but
rather on those damaged by rheu..~atic fever or with congenital defects.

The condition has a high mortality, both
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in its acute and subacute forms.

Most of the symptoms

are caused by embolic phenomena.

Modern treatment in-

volves the use of penicillin and anti-coagulants.
Endocarditis, because of its poor prognosis and lack
of specific treatment was a natural candidate for the
use of transfusione
di sapoointing.

In general the results have been

Vvordley ( 249) has reported a case with

recovery following specific immunotransfusion.

Kurtz

and White (134) reported a case and reviewed the literature up to that time (1929), stating that encouraging
reports were in the minority.

Their patient was treated

by exsanguination transfusion, receiving 1800 cc. of
irnnru.ne blood following the removal of 1000 cc.

Later

she received many transfusions of similar amount.

There

was some progress, but she died after seventeen months
of illness.
Kilgore (130) reported three cases treated with immune serum and blood in rather large amounts.

He stated,

uAll were improved in their own and their families' ooinion, but in none could I see a~y beneficial effect other
than temporary relief of anemia and the psychic uplift
to be expected from any strange or elaborate treatment.

11

At the present time, there are no studies which reveal the exact status of blood therapy in this condition
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in relation to the most recent advances in treatment.
ERYSIPl::L.i-1.S

Erysipelas is a severe staphylococcic disease of the
skin.

Its treatment by the use of the sulfonamides is

very effective.

Before such specific therapy was avail-

able, blood trRnsfusions had been successfully employed
in the condition.

Blanchard and Bell (25) in 1934 repor-

ted the reduction in mortality from erysipelas by the
use of transfusion.

In the age group less than six

months, they had a mortality of 44%, compared with a
standard of about 70%; similar reductions for other ages
were acheived.
The present status of blood treatment in erysipelas,
as in many other diseases is in doubt because of the
efficacy of specific therapy.

INFBCPIOUS HEPATITIS
Infectious hepatitis is probably of filterable virus
etiology, and is characterized by jaundice and relatively
mild constitutional symptoms.
demics.

It often occurs in epi-

It is known to have been transmitted on a num-

ber of occasions by the use of sera containing the infectious agent.
~
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Stokes and Neefe (2lo) recently reported an attempt
to prevent infectious hepatitis.

Of 291 persons in a

summer camp exposed to the disease, 45 were injected with
globulins prepared by plasma fractionation.
was 0.15 cc./lb. given intramuscularly.

The dose

The authors con-

cluded that there was a statistically significant lowering of the incidence of hepatitis in the injected persons.
The earlier the injection was given, the better the results.

'.l.'hey further felt that globulins would have some

therapeutic action if ~iven shortly after the onset of
the disease.
MEASLES

Prophylaxis of Measles
Prophylaxis of measles may be divided into prevention, in which the aim is to prevent the disease from
ocurring in a contact, and attenuation, in which the
aim is to produce the disease in a weakened form.

Pre-

vention is advised for children less than two or tbree
years of age, for children just recovering from some
severe illness, and for institutions, while attenuation
is desirable for other children.

In either case, the

individual is said to have been ttprotected 11 against
measles.
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In the evaluation of the results of various investigators, several facts concerning the epidemiology of
measles nmst be recognized.

Contact in hospitals is low.

The highest incidence of measles following contact occurs
in poor homes with bad hygeine and crowding.

A lower

incidence is found in better homes where the sick child
is isolated (126) •
The first investigator to use a blood product in the
treatment or prevention of measles was Gienci (47) in
1907.

Subsequent reports on the use of this and other

preparations have been so numerous that only the more
significant can be reviewed here.
Whole blood has been used in measles by only a few
investigators.

Haas and Blum (98) in 1926 used five to

seven cc. of convalescent blood in an orphana~e epidemic,
and found that it gave 41% pro·cection (both prevention
and attenuation).

Blauner and Goldstein (26) reported

unsuccessful results in the use of 30 cc. of imr.mne
adult whole blood.

If the injected children, 88% had

measles, while only 60;t of those not injected had it.
In contrast with the above unsuccessful results,
convalescent serum has given in the hands of most workers
protection rates of 90% or above. (34, 140, 180, 252).
'l'he most recent reoort in the literature on this subject
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is that of Stillerman, Marks, and Thalhimer (214),
who used the material on home exposures.

Prophylactic

injections were given up to the eighth day of exposure,
the appearance of the rash in the original patient being
considered the fourth day.
Under 1 yr.
Prevention:
Modification:

10 cc.
5

Their recow.Jnended doses were:
1 yr.

2-3 yr.

Over 3 yr.

15

20

20.;;.

5

10

10

-~Success in prevention in this a.ge group was not
great, the majority obtaining only modification.
They found that increase of dosage beyond a certain
point gave little more protection.

The percentage of

prevention in their series was only fifty, which is low
compared with those of other investigators.

This the

authors attributed to the facts that they were working with
home contacts, and that every case was seen at least
every other day by a physician, and thus many mild cases
which would otherwise have been missed were found by them.
At the present time, convalescent measles serum is
available commercially.

The dosage advised is 10 cc. for

ages less than six, 15 cc. for ages six to twelve, and
20 cc. for older ages.

If prevention is desired such

doses should be given before the sixth day, while for
attenuation they should be given on the sixth or seventh
~
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day.

If prevention is desired after the sixth day,

I"

the dose should be increased, but results are unreliable.

!I

I,

After the seventh day, injection is of little benefit. (7)

ii

Innnune adult serum has been used in the prophylaxis
of measles; in general it has been found that results
are similar to those with convalescent serum if doses
three to four times those of convalescent serum are used
(252).

Morales and Mandry (168) found that irrnnune adult

serum in doses of 20 to 40 cc. gave high protection rates
(97%).

Adult serum has not become ~opular because of the

large doses required.
Much work has been done on the use of placental
globulin#:1, first prepared in 1933 by I,1cKhann and Chu ( 162)
by the extraction with hypertonic saline of ground normal
placentas.

Further work has demonstrated that placental

globulin is as adequate as convalescent serum in the prevention and treatment of measles.

It may be obtained

commercially, and the recommended dosage is 2 to 10 cc.
for prevention and 2 to 5 cc. for modification (7).
Gamm.a Globulins in Measles
\,i th

the development of the plasma fractionation

program, large quantities of purified globulin were made
available.

It was found that these globulins contained
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antibodies against many infectious agents, including
measles. (71)

Early preparations contained eight to ten

times the concentration of anti-measles substances found
in normal plasma; later, as techniques became more refined, concentrations of fifteen to thirty-five times
those of plasma were obtained.(215)
The first to suggest the use of such purified plasma
derivatives was Robinson, in 1940 ,200).

Organized

clinical trials were made during tl1e winter and spring
of 1942-43 by several groups.
Stokes, Maris, and Gellis reported on cases from
Philadelphia and Baltimore, where, according to them,
the epidemics were of more than average severity.

The

preparation was so potent that it rather surprised the
investigators; at first larger doses than necessary were
used.
The dosages finally recommenc.ed, based on their
experience, were as follows:
For attenuation:
cc •

2.0 - 2.5 cc.

- 1.5 cc.

4.0 - 5.0 cc.

Age under 5:

0.25 -

Age over 5:

1.0

By weight:

o.5

For prevention:

• 02 cc./lb.

.08 cc./lb.

The physician's appraisal of the various factors
which determine the severity of the infection should be
~
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a guide to the amounts to be used.

For the purpose of

prophylaxis, the injection should be given within seven
days of exposure •
Ordman, Jennings, and Janeway (177) reported from
Boston.

There the dosage used was 2.5 cc. for children

under five, and 5 cc. for children over five.

An extreme-

ly high percentage of children (99% in family contacts)
obtained prevention or attenuation.

These authors con-

cluded that subsequent to the fifth day after exposure,
the adequacy of protection decreased.

Adequate doses gave

protection for two weeks.
In November, 1944, Janeway(ll9) reported all results
up to that time, a total of 1,108 cases.

There were only

three cases of measles with complications, and only thirtyone reactions in that number.
In December, 1944, Greenberg, Frant, and Rutstein
(197) of New York reported a comparison of purified plasma
globulins (gamma globul:ins) with placental globulins.
Only one dosage was used for all ages: 2 cc. of gamma globulin, or 5 cc. of placental globulin.

One hundred percent

of 814 children receiving the gamma globulin obtained
some degree of protection, whereas only 77'}6 of ninety
childred receiving placental globulins obtained similar
protection.

The authors stated thRt the single dosage
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scheme was superior to a varying scheme in that younger
children obtained prevention, whereas older children obtained modification.
Treatment of Measles
There are no extensive renorts on the treatment of
measles with blood products.

Levitas (144) used 1 to 2

cc. of placental globulin in severe cases of measles

with much cough and toxic reaction, with good results in
alleviating these symptoms.

Presumably the use of con-

valescent serum in corresponding doses would give equally
good results.
Gamma globulins were used by Stokes, Maris, and Gellis.
(215)

'l.'he results depended, as might be expected, on

whether or not the rash had appeared.

If given before the

ra.sh, 17 of 31 cases showed "greatly modified 11 measles;
if given after, only 6 of 30 had similar benefit.
Summary

At the present time, convalescent measles serum
is commercially available, and is adequate in the prophylaxis of measles.

Gamma globulins have shovm promise,

but are not generally obtainable as yet.
In the treatment of measles, fair results may be
expected following the use of one of the above products.
~
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11UMPS

The first use of a blood derivative in the prophylaxis of mumps was by Hess (108) in 1915.

He prevented

an epidemic in an asylum by giving injections of 6 to
8 cc. of convalescent serum to twenty children.

None of

them contracted the disease.
Convalescent serum in doses of 20 cc. or more should
be employed for prophylaxis.

Levinson and ,;iolf ( 143)

reported that of 157 patients receiving such injections,
only 8% had mumps, while with doses of only 10 cc., the
incidence was 19%.
Mumps is such a mild disease in children that the
use of prophylactic measures is probably not indicated
except in institutions such as hospitals or asylums, in
which the inconvenience of a long quarantine can be avoidded by the use of proper steps to stop an epidemic.
Prevention of Mumps Orchitis
In contrast with the condition in children, mumps
in adults, especially males, is rather serious because
of the high incidence of co:::iplications.

The aim of

therapy in adult cases of mumps is the prevention of
orchitis.
De Lavergne and J:i'lorentin ( 59) reduced the incidence
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of orchitis from 24 to 4% by the use of 30 cc. of convalescent serum •. The most recent large series was reported in 1942 by Bailey and Haerem from a naval installation.
They found that the incidence of orchitis in untreated
cases was 20%.

Cases treated with convalescent serum from

donors that had recovered from orchitis showed an incidence of 4.2%.

However, if the donors had not had it,

the incidence of orchitls in the recipients was 19.2%.
This indicates that if the prevention of this complication
is the aim of therapy, serum should be used only from
those who have recovered from it.
Rambar (188) used pooled Red Cross plasma in the
treatment of orchitis.

In two cases, the administration

of one unit caused the swelling and temperature to subside rapidly, in one instance in eight hours, in the
other in twenty-four.

PNEUMONIA
A few reports on the use of blood and its products
in pneumonia have appeared.

Arena (9) in 1937 found that

in addition to the correction of anemia, blood transfusion
caused prompt and marked symptomatic improvement in children with bronchopneumonia.

The temperature fell by

crisis within one day in fifteen of twenty-four patients
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and within two days in the rest.
plications was reduced.

The incidence of com-

'lhey failed to note any circu-

latory embarrassment; rather, dyspnea and cyanosia were
reduced.

Arena thought that possibly the beneficial

effect was due to a stimulus to the leukocytes.
A

comonly cited objection to the use of transfusion,

especially of plasma, in pneumonia is the danger of
causing pulmonary edema.

According to a recent report

by Armstrong and others (10), such danger is slight.
Edema will not occur except in the presence of hypoproteinemia, and there is a greater danger in giving large
quantities of saline than of moderate amounts of plasma.
They cited two cases in which plasma was used with good
success to control symptoms of pulmonary edema.

Both

received four to six liters of blood and plasma. The
blood was indicated on the basis of anemia, otherwise
plasma was used.
POLIOMYELITIS
The status of serum therapy in poliomyelitis is in
doubt.

barly injection is advisable, since it is probable

that once the virus reaches the nervous tissue, serum is
useless (208).

Schultz and Gebhardt found that the intra-

muscular injection of convalescent serum into monkeys with
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the disease was satisfactory only within the first twentyfour hours of the disease.
An interesting report from the Navy states that

several cases were treated early with pooled normal
plasma because of the lack of specific serum.
ed about 2000 cc. in a period of one day.

All receiv-

i'he response

1

was "spectacularn, according to the authors, Barnum and
Bower (12).
RHElTh1ATIC AND HHEUMATOID AR'rHRITIS

A few isolated reports on transfusion in arthritis
have appeared.
Rheumatoid arthritis is a disease of mysterious
etiology characterized by deformity, ankylosis, and
atrophy of the joint structure.

Like all diseases of

doubtful etiology and unsuccessful treatment, transfusion
has had its share of trials.
ported thirteen cases.

Copeman (52) in 1931 re-

Transfusions of 500 cc. were

followed by vigorous physical therapy.
sustained, but not spectacu;Lar benefit.

All cases showed
'lhree cases of

osteoarthritis had no similar benefit.
Rheumatoid arthritis is a disease characterized by
remissions; evaluation of any therapy is difficult.
The report cited above is open to the objection that the
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physical therapy may have been of more benefit than the
transfusions.
In rheumatic fever, a few reports on therapy by
transfusion exist.

Weiss (243} has reported a case

which was transfused in spite of active carditis.
day later, the temperature began to come down.

One

Several

more transfusions were given, and the temperature gradually fell to normal.
Isolated reports such as this are of little value
in deciding the exact value of transfusion in rheumatic
fever, although such value is probably slight.

SCARLET F'EVJ:<.;K
Scarlet fever is caused by a. streptococcus which
elaborates a specific toxin.

Antobodies against this

toxin are present in convalescent blood and serum.

These

have given good results in the past, and at the present
time, scarlet fever immune serum is official in the U.S.
Pharmacopeia.

'l'he recommended dosage for prophylaxis is

10 cc. for children under si:x, 15 cc. for children from
six to twelve, and 20 cc. for older persons.

The injec-

tion must be repeated in ten days if the individual is
continuously exposed.

It is stated that convalescent
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serum appears inadequate to deal with complications (7).
A few of the most important contributions to this
subject will be reviewed.

Gordon (95) in 1933 studied

13,000 cases of scarlet fever.

Direct transfusion of

100 to 500 cc. given in the more severe cases succeeded

in reducing the mortality to half of what it had been
before this procedure came into use.
Hoyne, Levinson, and '17halhimer (115) found that prophylactic injections of convalescent serum in home contacts gave protection rates of 97%.

The dosage used was

10 cc. for children less than two, and 20 cc. for older

children.

In treatment, the authors obtained results

similar to those of Gordon; injections given before the
third day in the most severe cases reduced the mortality
to half of the former figures.

They found that the tempo-

rary immunity obtained from the prophylactic injections
lasted only two weeks •
Levinson and Wolf (143) in 1941 studied 4595 cases
of home contacts and obtained 97.7~; protection using
doses of convalescent serum somewhat smaller than those
recommended by the Pha.rmacopeia.

'11hey

treated scarlet

fever with doses of 20 to 100 cc. v:i th good results.
Since the introduction of the sulfonamides, they
have been the chief reliance in therapy.
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articles have indicated that sulfonamides are inadequate
to deal with toxic symptoms.and the rash.

Hence, con-

valescent serum is used to treat these, and the sulfonamides are used only for the prevention and treatment of
complications.

Fox and Gordon (84), for example, re-

ported two thousand cases, and recommended the following
dosages for treatment:
Moderate

Severe

Infants.

10 - 20 cc.

20 - 40 cc.

Children.

20 - 30 cc.

30 -

Adults.

20 - 40 cc.

40 - 80 cc.

60

cc.

Following such injections, there was a reduction in
the fever, and the other signs and symptoms subsided.
There was a lowered mortality and morbidity.
SEPSIS
Sepsis is a general term applied to severe streptococcal or staphylococcal infections with blood stream
invasion.

It may originate in the female genital tract

following childbirth or abortion, or it may follow mastoiditis with invasion of the lateral sinus, or other
conditions •
Until the introduction of the sulfonamides and more
recently of penicillin, blood transfusion was the only
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satisfactory therapeutic measure available.

Plain blood

transfusions, immunotransfusion, and the auto-transfusion
of irradiated blood have all been used.

A few of the

more pertinent articles will be reviewed.
Whole Blood in Sepsis
Blood transfusions have given good results in the
treatment of sepsis.

Kilduffe and DeBakey (129, p. 82)

cite more than forty articles reporting successful use.
Stetson (213), for instance, reported sixty-eight cases
with a mortality of 51%.

He said to begin treatment early

and to transfuse 500 to 600 cc. of blood every two days
until the blood culture became negative.

He advi.sed

withdrawal cf one-half to two-thirds of the amount to
be injected before the transfusion was begun.

He also

stated that he found that immunized donors were no better
than ordinary donors •
Roehm and Barker (201} reported six cases of childhood sepsis, of which five recovered.

They advised about

300 cc. of blood every day or every other day.

If the

desired results were not· obtained after any one transfusion)
a new donor was procured.
Cadha.m (39) reported one hundred cases.

His system

of treatment was to use 30 to 50 cc. of hu.~an serum at
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one to two day intervals and rabbit serum against organism in doses of 3 to 5 cc.

His mortality rate was 10.5%.

He believed that serum was better than blood because the
cells reduced the patient's complement.

The mortality

rate before this system was instituted was over 85%.
A few investigators reported less favorable results
with transfusion.

Kordenat (131) found from experience

with twelve cases of streptococcus septicemia that the
prognosis with transfusion depended on the type of organism and the length of the chain of cocci.

Infection with

beta-hemolytic long chained organisms was fatal in all
cases, whereas the short chained alpha-hemolytic organisms
gave a prognosis of recovery in two of five.
Immunotransfusion
The first to use immunotransfusion were Satterlee
and Hooker (205), who in 1914 reported one case of
staphylococcus septicemia.

Wright (249a), in 1919 re-

ported the use of such transfusions in infected war
wounds; later reports by him and his co-workers extended
the theory and practice of this form of transfusion (50).
Unger (230) reported o4 cases of sepsis.

Nine of

forty-two cases treated with ordinary transfusion died.
Seven cases treated by immunotransfusion died, but it was
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found that the donors had not been satisfactorily immunized.

Later a recovery rate of eight of fifteen cases

in which the immunization was satisfactory was established.
(A brief statistical test indicates these results are
significant, but only barely so.)
Dyson (64) reported several cases, and advised that
the immunized donor be given nucleins to increase his
white count before the transfusion.
Gill (92) repored four cases of lateral sinus infection, which, according to many authors, has a better
prognosis than other forms of sepsis.

He advised small,

repeated transfusions of 150 cc. of blood from immunized
donors.

The response was immediate.

Lyons (149) made no attempt to immunize the donors,
but rather selected those individuals who already had
high content of antibodies in their blood.
Some authors have considered that the value of immunotransfusion is no greater than th2t of the blood injected.

filddell (192) made the interesting finding that the

antibody content of the patient's blood was higher than
that of the donor's blood.
The actual value of immunotransfusion as compared
with plain whole blood transfusion will probably never
be known, since the advent of the sulfonamides and peni-
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cillin has removed the necessity for relying on blood
transfusion alone in the therapy of sepsis.
Auto-Transfusion of Irradiated Blood
A number of enthusiastic reports have appeared advocating the irradiation with ultraviolet light of the
blood of patients with sepsis.

The first report appeared

in 1934, written by Hancock and Knott (101).

Hancock

has reviewed the rationale of the procedure (100).

He

stated that it inactivates the toxins, destroys and inhibits bacteria, increases the oxygen combining power of
the red cells, produces vitamin D, and increases cellular
permeability.

He further stated that the red cells absorb

the radiation and give it off later all through the blood
stream.

Clinically, the sedimentation rate is reduced,

toxic symptoms are lessened, and blood cultures become
negative.

The bactericidal properties depend upon the

fact that the bacterial cells are smaller and contain relatively large quantities of the photosensitive substances
phenylalanine and tyrosine.

The technique involves the

withdrawal of one-twelfth to one-sixteenth of the blood
volume, citrating it, and returning it to the circulation
through a special irradiating chamber.
A recent report by Miley (165) indicates that irradi-
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ation is superior to sulfonamides in staphylococcus
infections.

Furthermore, the presence of those drugs

inhibits the action of the ultraviolet rays.
The status of the irradiation of blood is as yet
indefinite.
Modern Treatment of Sepsis
Although, as stated before, the chemotherapeutic
agents penicillin and the sulfonamides have taken their
place with blood as therapy available in sepsis, yet it
must not be thought that transfusion has no use in the
treatment of the disease.
Chandler and Janeway (45) reported in 1939 on three
cases that showed poor response to sulfanils.mide alone
but made immediate improvement with transfusion.

'rhe

authors stated that transfusion and sulfonamides together were far superior to either alone.
Hartman, Vfolff, and Love ( 105) reported in 1942 on
nineteen cases of sepsis associated with lateral sinus
involvement in children.

'l'heir mortality with the use

of sulfonamide and multiple transfusions of 150 to 250
cc. was 10.5%.

The n1ortality before the use of the drug

was 35%; presumably this included cases treated by transfusion alone.
"1,,1
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Sunm1ary
Sepsis is too serious a condition to rely on one
therapeutic agent exclusively.

If the use of a drug

gives immediate and satisfactory response, no further
therapy is indicated; however, if the response is not
adequate, repeated transfusions should be performed.
Whole blood is probably the blood product of choice in
this condition.
SYPHILIS
No reports have anpeared lately on the treatment of
syphilis with transfusion.

Bragin (29), a Russian worker,

recently has noted that the blood of persons in late
stages of syphilis has the power to reverse the Wasserman reaction in the early stages of the disease.

Such

reversal lasts about a month.
'rUBhRCULOSIS
Occasional groups of workers have purported to prove
that there is value in transfusion in tuberculosis.
Bundsen (35) for example, used small transfusions of
15 to 20 cc. in fifty cases of tuberculosis, and found

that thirty-one were materially improved, eleven were unchanged, while the others had unfavorable effects of one

...,_,,
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sort or another.

He stated that the well-being and

mental attitude of the patients was improved by the procedure.
The effect was probably psychogenic, since the doses
used were too small to have any possible effect.
Freilich and his co-workers (88) used transfusions
of 100 to 375 cc. in advanced cases, and found that the
clinical course of the disease was not altered.
TYPHOID FEVnR
Lantin and Guerrero (137) reported in 1936 from the
Philippenes on the use of transfusion in the treatment
of severe typhoid fever.

They removed 150 cc. of the

patient's blood and replaced it by 200 cc. of blood f'rom
a donor.

If there was no favorable response, or if

marked toxemia returned, the procedure was repeated on
the next day, 8nd then as often as necessary at intervals of two to four days.

They stated that the removal

of blood aided the detoxication.

In cases with much

intestinal hemorrhage, the bleeding was not necessary.
'rheir cases treated in this manner had a recovery rate of
47%, as compared with only 24% recoveries in control
series.
Habel and Crocker (99) in the same year reported
~
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the use of immunotransfusion in five cases all infected
at the same time.

The donors were injected with typhoid

vaccine, and blood was taken from then about eight hours
later to be given to the patients.
on two successive days.

This was repeated

fmiounts of 100 to 200 cc. of

blood were transfused.
i'he five cases given this treatment showed an immediate favorable response no matter what the duration
of the infection.

The authors stated that the result

of the injection of the vaccine was not to increase the
anti-typhoid substances in the blood of the donor, but
rather had a non-specific effect on the immune powers.
The use of donors who had recovered from typhoid fever
met with little success.
SUMMARY

We may divide the use of blood and its derivatives
in various infections into several groups as follows:
In measles, convalescent serum or gamma globulins
are specific therapy for both prophylaxis and treatment.

In infectious hepatitis, globulins are probably also
similarly spec1fic.

Mumps orchitis may be Drevented or

treated by convalescent serum, or pooled normal plasma.
Poliomyelitis serum and pooled normal plasma are of some

'-11
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use in that disease if given early.
The second group consists of conditions in which
blood at one time was the only known therapy, but for
which more specific agents now exist. In sepsis, whole
blood transfusions are indicated in many cases in addition
to the use of sulfonamides.

Whether penicillin will re-

move the necessity for this is not known.
transfusion is probably not necessary.

Immuno-

The irradiation

of blood is a procedure which has shown much promise,
but which has not been generally adopted.
·rn erysipelas, sulfonamide therapy has made unnecessary the use of blood or serum, except in unusual
cases.

In endocarditis, modern treatment is far superior

to transfusion, which 3.lways had doubtful status, and it
is probable that blood is not indicated.

In scarlet

fever, the sulfonamides for a time were considered specific and the use of serum unnecessary, but there is a
trend at the present time towards the use of serum as the
mainstay of therapy, with the sulfonamides being administered only for the prevention and treatment of complications.

Serum is ineffective against the complications

of the disease.
The third group consists of diseases in which success has been observed following the use of a transfusion,

'-"
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but in

which the status is doubtful.

typhoid fever are examples.

Brucellosis and

The use of plasma in pneu-

monia has recently been advocated on the rationale that
the increase in plasma proteins will diminish pulmonary
edema, but further study is necessary to decide the
exact value of this therapy.
In the fourth group, we may include diseases in
which the value of transfusion is confined only to nonspecific effects.

Hheum.atic and rheumatoid arthritis

and tuberculosis be long in this group.

'l'he temporary

reversal of the Wasserman reaction following the injection of blood of late syphilis is interesting, but
of no value in treatment.
The beginning words of this chapter should be repeated here:

Infections may lead to non-specific con-

ditions such as hypoproteinemia or anemia; the correction
of these in a long-standing chronic disease may be of
great benefit to the patient, and mey even be instrumental in final recovery.
expected.

But miracles should never be

Blood therapy is replacement therapy, and if

there is nothing that needs replacement, little benefit
can be anticipated •

._,.
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CHAPTER VIII
MISCELLANEOUS CONDITIONS
There are certain conditions in which transfusions
have been used which do not fit into any of the classifications previously discussed.

Poisonings, eclampsia,

uremia, nephritis, and increased intracranial pressure
make up the indications taken up in this chapter.

POISONINGS
Poisonings with various substances have been treated
by transfusion.
1. Carbon monoxide:

Carbon monoxide unites with

the hemoglobin to form a compound more stable than the
combination of oxygen and hemoglobin.

Thus, the oxygen

carrying capacity of the blood is reduced.
Carbon monoxide poisoning has been treated by the
technique of exsanguination transfusion, in which blood
is first removed from the patient and then replaced by the
blood of a donor.

L.B. Robertson (194) used this pro-

cedure on two soldiers buried by an explosion; although
there was no immediate effect, they were improved the next
day, and finally recovered •
Later this author advocated the procedure for many
conditions: burns, erysipelas, "acute intestinal intoxica-
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tion", resorcin poisoning, and malignant scarlet fever. (195)
J\ccording to Robertson, this technique is of
greatest value in children, where the amounts needed are
smaller.

A volume of blood of 35 cc./lb. is first re-

moved, and then a transfusion of a slightly greater amount
is given unless the child is cyanotic, in which case
slightly less is given.
2. Benzene and nitrobenzene: Benzene and nitrobenzene act upon hemoglobin to form methemoglobin, a substance which cannot carry oxygen.
tic anemia.

They also produce aplas-

Kildiffe and DeBakey (129) cite a number of

foreign authors who have treated such poisoning by the
use of transfusion.
3. Mercuric chloride:

Mercuric chloride acts on

the renal tubules to produce severe kidney damage.

Ex-

sanguination transfusion has been advocated in this condition.

Burmeister (36), 1910, stated that almost one-

third of the mercury was contained in the blood after administration of the chloride by mouth.

In animals he

performed continued bleedings and transfusions until about
100 to 150% of the blood volume had been replaced.

These

animals lived two to eight hours longer than controls,
and the renal lesions were less severe.
Hashinger and Simon (107) reported cure of a case
'wf
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At the end of the second day, the patient was bled of
850 cc. of blood, and then given a 1000 cc. transfusion.
bach subsequent day a similar procedure was carried out,
using smaller amounts.

After two weeks, recovery took

place.

ECLAMPSIA
'1:here are a few reports on the successful treatment
of eclamp.sia with transfusions.

Benaron and Farnswort:t1

(14a), for example, used 750 cc. of serum in a case on the
rationale that the edema might have been due to low serum protein.

'l'here was an increase in the urinary out-

put with a drop of the specific gravity, and a fall in the
hematocrit, all within twenty-four hours.

At that time,

premature labor began, and the patient went on the a
successful recovery.

on the other hand, Muirhead and Hill (172) .found
that in twenty-eight cases of eclampsia and pre-eclampsia,
the blood pressure was not controlled by injections of
concentrated plasma, although in some instances, temporary benefit was obtained.
UREMIA
Uremia is the retention of waste products caused by
a decrease in renal function.

'-"
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The procedure of "exchange
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transfusion" has been advocated in this condition; it
is almost equivalent to the "crossed circulation" method
which is so valuable in experimental physiology.

The

blood of the patient is transfused into the donor at the
same time that the donor's blood is transfused into the
patient.

It was used experimentally in nephrectomized

dogs by Thalhimer, Solandt, and Best (222), 1938, who
succeeded in keeping the animals alive as long as the
procedure was continued.
The same technique was used in humans. by Duncan, Tocantins, and Cuttle (61), who treated two cases, one
with chronic glomerulonephritis, and the other with polycystic kidney disease.

Both improved following the trans-

fusion, and there were no significant reactions in the
donors.

In one of the cases, 7000 cc. of blood were ex-

chaneed in 47 minutes.
Slagle and Pons (211) treated a case of anuria following mercury succinamide poisoning by a similar technique.

One liter of blood was withdrawn from the patient

and the donor, and each was transfused with the other's
blood.

This was repeated five times in four days; after

the ninth day, the patient finally passed some urine,
and he was apparently doing well when he died of a vertebral
artery hemorrhage on the eighteenth day.
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NEPHRI'I1IS

Nephritis is a condition characterized clinically
by albuminuria, hematuria, hypertension, anemia, edema,
and late by great decrease in all kidney functions.
Mosenthal and Ashe (169) reviewed the subject in
1930, and stated that there was little danger in transfusion even in severe nephritis.

The dangers of raising

the blood pressure, producing toxins, or aggravating the
renal lesions, which were objections commonly cited at
that time, were, according to them, over-estimated.

They

summarized the indications for transfusion in nephritis
as follows:

to relieve anemia, and to combat edema by

raising protein levels.

'l'he treatment of anuria by use

of transfusion was without results; any benefit which resulted they considered coincidental.
Recently Thorn (825) has reviewed the use of blood in
nephritis.

He considered anemia and hypoproteinemia to

be the indications, preferring puri.fied albumin to concentrated ~lasma for the latter because of its lower content of electrolytes.

He stressed the temporary benefit

of protein injection, and advised repeated doses of 25 gm.
per day were necessary for any benefit.
Thorn considered albumin to be indicated in cases
with edema in the absence of cardiac failure.

"-'
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sence of edema, albumin was indicated only in cases with

continued vomiting.

INCREAS~D INTRACRANIAL PID.;SSURE
Jm

increastin intracranial pressure may be due to

trauma, tumors, congenital defects, or other conditions.
Hypertonic solutions of glucose or .sucrose are generally
given in such cases to dehydrate the brain and to draw
off cerebrospinal fluid.
It was suggested by Hughes, Mudd, and Strecker (116)
that concentrated serum {4X) be used in place of the
sugar solutions.

Serum would have the advantage that

the proteins contained in it would be eliminated less
rapidly than the carbohydrates.

They reported its effects

in nine patients; a dose of 50 cc. was used in most
cases.

Reduction in pressure was innnediate and well-

sustained in all cases.

1~e authors felt that the con-

centrated electrolytes of the serum accomplished the
initial lowering, and this was sustained by the action
of the colloidal proteins •
An

attempt was made to use concentrated serum sus-

pended in 50;s sucrose, but the solution was too viscous.
Animal experimentation was done later to prove that the
benefit from the serum injection was not due to leakage

.._,,

around the pressure recording instruments (250).
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SUMMARY
In carbon monoxide poisoning, blood may be indicated
in certain cases; but probably the majority of cases will
recover or not without the benefit of such therapy.
In benzene poisoning, blood is indicated in cases of
aplastic anemia; otherwise, remarks similar to those above
hold in this condition.
In mercuric chloride poisoning, eclampsia, and uremia
the reports of successful use of transfusion are all open
to the objection that the patients might have recovered
without it.

The procedure of exchange transfusion seems

to have met with success.
In nephritis, indications for transfusion reduce to
our old friends, anemia and hypoproteinemia.

The edema

of nephritis is to some extent due to sodium retention;
therefore the correction of hypoproteinemia may not relieve the edema.
In increased intracranial pressure, concentrated
serum has met with good results, but has not become adopted, probably because of the expense involved.

It is inter-

estin~ that this is a rational use of a blood derivative
Q

which is not based on replacement •

..,_,.,
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CHAPTER IX
SUMMARY

Blood therapy is as rational as any other form of
therapy, and is based on the principle of replacement.
There must be some consituent of the blood which, when
given to the patient, will benefit his condition.

With

only rare exceptions, all the states in which blood can
be said to be successfully used exemplify this rule.
However, the converse is not true.

In certain con-

ditions, for example, leukopenia, attempts at replacement
do not meet with success.

In other conditions, as hypo-

proteinemia and hypoprothrombinemia, o.ther means of replacement are more effective and less expensive, and blood
or a derivative is last choice.
We may review the various indications as follows:
Blood or a derivative is indicated in:
1. Shock: Whole blood, plasma, or albumin may be used.

Whole blood is preferred for hemorrhagic shock, but pla.sma
or albumin may be used if the hemoglobin is over 507~.
Plasma and albumin are preferred for other forms of shock.
In burn shock, large quantities may be necessary.

Concen-

trated ylasma or albumin may be used if proper attention
is given to the maintenance of fluid intake.
2. Hypoproteinenrl:a:
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Plasma or alburain should be
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used only when other therapy has failed, or as prophylaxis against a post-operative fall.
3. Anemia:

Whole blood or red cell suspensions

should be used in severe nutritional or post-hemorrhagic
or pernicious anemias (below 25% hemoglobin); or in less
severe anemias of the same types if an operation is planned;
in aplastic anemia; and in certain hemolytic anemias. In
acquired hemolytic icterus, blood seems specific; in
familial hemolytic icterus, reactions are frequent, and
transfusion should be used cautiously; and in erythroblastosis fetalis, Rh negative blood should be used.
4. Hemorrhagic State~:

Blood is specific for tempo-

rary control of the bleeding tendency in hemophilia. It
is of value in thrombocytopenic purpura, functional uterine
bleeding, and probably in fibrinogenopenia.

It is indi-

cated in hypoprothrombinemia which cannot be corrected by
the administration of vitamin K; that is, associated with
severe liver damage.
5. Inf'ections:

Convalescent serum is of value in

treatment and prophylaxis of measles, mumps, and scarlet
fever.

Measles and infectious hepatitis have oeen treated

a.nd prevented by the use of gamma globulins.

The status of

poliomyelitis serum is uncertain; it is often used.
Whole blood is indicated in any case of sepsis

..._..

which does not respond well to chemotherapy •
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'6. Increased Intra.cranial Pressure:

Concentrated

plasma gives more sustained lowering of the intracranial
pressure than do sugar solutions, and is prob~bly indicated in certain cases.
II.

Blood is of doubtful status, but is worth trying in:
1. Neohrosis:

Concentrated serum has given good

results in lipoid nephrosis in the hands of certain investigators.
2. Pneumonia:

In certain cases, pulmonary edema

may be decreased by the administration o:f serum or plasma.
III. olood is not indicated in the following conditions
unless some other condition which is itself an indication
is also present:
1. Leukop~nJa:

Blood is inferior to specific

therapy.
2. Infections:

Brucellosis, diphtheria, endo-

carditis, erysipelas, syphilis, tuberculosis and typhoid.
Blood has been advocated in all these conditions; out in
all, the evidence is insufficient, or more modern therapy
has removed the necessity for use of blood or its derivatives.
3. Poisonings:

In none of the poisonings dis-

cussed has it been shown that the use of blood has pro-

.._,,

duced any real benefit •
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4. Nephritis:

Nephritis is not of itself an indi-

cation for transfusion, although the associated anemia and
hypoproteninemia may be.
5. Uremia:

Exchange transfusion has given rather

spectacular results, but is still in the experimental
stage.
6, Eclam.~sia: No benefit from plasma has ever been

proved.
The present war has increased the use of transfusion
enormously; the use of red cell suspensions and the plasma
fractionation nrogram are direct outgrowths of it.

When

the Red Cross program of volunteer blood donor procurement
is discontinued, as it will be if no arrangements are made
for its continuance, many of the advances in blood therapy
will be lost merely because of the lack of material. If
bovine plasma or albumin is a satisfactory substitute for
human plasma, unlimited quantities of these substances will
be available in the future; but only from human plasma can
immune globulins against human diseases be prepared, and
this is the most promising development of the plasma fractione.tion program at the present time •
It is to be hoped that there will be no reduction of
the progress ·of research in this field in the future.
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